Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028271	cb-laktaat	mmol/l (mmol/l)	6147	11399	1.74%
3028271	cb-laktaat	— (—)	218	232	100.00%	Distribution not available
3028271	cp-laktaat	mmol/l (mmol/l)	140	301	0.00%
3028271	laktaatti(verikaasulaite),kapillaariveri	mmol/l (mmol/l)	130	223	0.00%
3028271	laktaatti(verikaasulaite),kapillaariveri	— (—)	14	14	100.00%	Distribution not available
3028271	cp-laktaat	— (—)	6	14	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified

1166

2853

3.55

318.92

2.5

1.6

1.73

mmol/l

0.02

1140

2789

Bacterial infection, other or unspecified

1105

2704

3.65

316.72

2.5

1.6

1.75

1.72

mmol/l

0.35

1081

2642

Contact with and exposure to communicable diseases

679

1392

5.02

307.92

2.0

1.8

1.69

1.76

mmol/l

0.82

664

1360

Other bacterial diseases

1964

3733

3.41

307.65

2.3

1.6

1.72

1.76

mmol/l

0.99

1919

3647

Implicit Sepsis

1714

3099

4.30

307.65

2.5

1.5

1.71

1.75

mmol/l

0.71

1667

3035

Other septicaemia

964

2074

4.65

307.65

2.8

1.7

1.63

1.71

mmol/l

1.54

943

2030

Influenza and pneumonia

2008

3802

3.43

307.65

2.3

1.6

1.64

1.81

mmol/l

8.71

1966

3706

Presence of other functional implants

1315

2496

3.77

307.65

2.0

1.8

1.65

1.77

mmol/l

4.09

1292

2418

Dyspnoea

1779

4082

3.29

307.65

2.2

1.8

1.68

1.77

mmol/l

3.32

1745

3975

Other medical care

1048

2468

3.94

307.65

2.2

1.7

1.76

1.75

mmol/l

0.10

1029

2402

Other heart diseases

819

965

5.67

307.65

2.2

1.5

1.71

1.77

mmol/l

0.67

800

950

Persons encountering health services in other circumstances

1211

2211

5.70

307.65

2.3

1.7

1.74

mmol/l

0.05

1189

2165

Chronic kidney disease

855

1871

4.69

307.65

2.8

1.7

1.51

1.74

mmol/l

10.00

842

1828

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1765

2728

4.01

307.65

2.3

1.5

1.63

1.85

mmol/l

10.28

1727

2657

All kidney diseases

1921

3897

3.44

307.65

2.4

1.6

1.63

1.79

mmol/l

8.23

1878

3799

Septicaemia

1058

2290

4.49

307.65

2.8

1.7

1.65

1.72

mmol/l

1.57

1037

2240

Other bacterial diseases

1957

3730

3.61

307.65

2.4

1.6

1.72

1.75

mmol/l

0.45

1918

3642

Other disorders of fluid, electrolyte and acid-base balance

876

1788

4.88

307.65

2.7

1.7

1.73

1.72

mmol/l

0.10

859

1742

Implicit bacterial Sepsis

993

2008

4.55

307.65

2.8

1.6

1.72

1.75

mmol/l

0.28

969

1971

Renal failure

1265

2603

4.48

307.65

2.8

1.7

1.60

1.77

mmol/l

6.29

1240

2540

All pneumoniae

1995

3866

3.53

307.65

2.3

1.6

1.65

1.80

mmol/l

7.70

1954

3768

Fever of other and unknown origin

1336

2363

5.20

307.65

2.3

1.6

1.64

1.72

mmol/l

1.92

1310

2299

Pneumonias (Asthma/COPD co-morbidities)

1982

3860

3.53

307.65

2.3

1.6

1.65

1.80

mmol/l

7.55

1941

3762

Renal tubulo-interstitial diseases

1880

3756

3.83

307.65

2.5

1.6

1.64

1.77

mmol/l

5.85

1843

3661

Bacterial Sepsis

1122

2219

4.48

307.65

2.8

1.5

1.73

1.75

mmol/l

0.18

1095

2176

Heart failure, strict

1286

2578

3.63

307.65

2.4

1.7

1.70

1.73

mmol/l

0.57

1264

2505

Heart failure,strict

1194

2094

4.16

307.65

2.4

1.6

1.70

1.74

mmol/l

0.70

1173

2028

Heart failure, not strict

1551

2840

3.81

307.65

2.3

1.6

1.67

1.77

mmol/l

2.74

1522

2758

Explicit Sepsis

1089

2246

4.70

307.65

2.8

1.5

1.65

1.73

mmol/l

1.90

1067

2204

Heart failure and antihypertensive medication

621

604

7.01

307.65

2.5

1.6

1.69

1.73

mmol/l

0.27

607

591

All chronic kidney diseases

1225

2550

4.05

307.65

2.6

1.6

1.55

1.77

mmol/l

11.21

1203

2486

Acute renal failure

656

1263

5.49

307.65

3.1

1.7

1.65

1.73

mmol/l

0.92

640

1232

All-cause Heart Failure

1257

2543

3.60

307.65

2.4

1.7

1.70

1.73

mmol/l

0.43

1235

2472

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1906

3923

3.39

307.65

2.3

1.6

1.65

1.79

mmol/l

6.24

1866

3824

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1788

4228

2.97

307.65

2.3

1.7

1.67

1.76

mmol/l

3.16

1744

4128

General symptoms and signs

1760

2742

3.27

307.65

2.0

1.6

1.74

mmol/l

0.05

1729

2671

Implicit Sepsis

1754

3252

4.05

307.65

2.5

1.5

1.72

1.75

mmol/l

0.36

1705

3185

1765

2728

4.01

307.65

2.3

1.5

1.63

1.85

mmol/l

10.28

1727

2657

Malaise and fatigue

1033

1949

4.38

307.65

2.5

1.7

1.73

1.74

mmol/l

0.06

1012

1897

Abnormalities of breathing

1632

2732

3.54

307.65

2.0

1.7

1.71

1.83

mmol/l

3.41

1605

2649

Condition for Implicit Sepsis (Organ dysfunction codes)

1744

3276

3.85

307.65

2.4

1.5

1.74

mmol/l

0.02

1695

3210

Pneumonia, organism unspecified

1904

3567

3.84

307.65

2.3

1.6

1.64

1.81

mmol/l

8.85

1863

3484

Condition for Implicit Sepsis (Organ dysfunction codes)

1768

3304

3.78

307.65

2.4

1.5

1.74

1.75

mmol/l

0.08

1724

3232

Implicit bacterial Sepsis

1054

2155

4.37

307.65

2.8

1.6

1.71

1.75

mmol/l

0.42

1027

2113

Covid-19 confirmed case

906

2343

4.01

307.56

2.4

1.8

1.62

1.74

mmol/l

2.84

884

2290

Persons with potential health hazards related to communicable diseases

768

1844

4.25

283.38

2.1

1.8

1.69

1.75

mmol/l

0.64

752

1800

Implicit viral Sepsis

670

1473

4.72

281.51

2.8

1.6

1.60

1.73

mmol/l

2.78

656

1447

Acute tubulo-interstitial nephritis

1127

3048

3.26

273.04

2.3

1.6

1.65

1.75

mmol/l

2.78

1105

2971

Atrial fibrillation and flutter

546

573

6.34

266.68

2.2

1.5

1.68

1.80

mmol/l

1.27

530

564

Implicit viral Sepsis

524

990

5.54

263.74

3.0

1.6

1.60

1.70

mmol/l

1.30

516

971

Viral Sepsis

524

992

5.53

263.14

3.0

1.5

1.60

1.70

mmol/l

1.36

516

973

Exposure to unspecified factor

1693

4765

2.60

261.51

2.1

1.8

1.72

1.75

mmol/l

0.43

1658

4647

Other heart diseases, wide

1393

2940

2.94

258.82

2.0

1.7

1.70

1.77

mmol/l

1.51

1360

2875

Persons encountering health services for specific procedures and health care

1734

4032

2.62

258.62

2.3

1.7

1.69

1.78

mmol/l

2.45

1706

3926

Convulsions, not elsewhere classified

521

981

5.42

257.41

2.4

1.7

2.18

1.74

mmol/l

6.59

507

954

COPD/asthma related infections

1538

2729

2.86

255.11

2.0

1.5

1.64

1.84

mmol/l

9.63

1508

2658

COPD/asthma/ILD related infections

1538

2729

2.86

255.11

2.0

1.5

1.64

1.84

mmol/l

9.63

1508

2658

Hypertensive diseases (excluding secondary)

735

928

4.68

253.98

2.1

1.5

1.70

1.78

mmol/l

0.87

715

914

Intracranial trauma

988

2020

3.50

252.78

2.1

1.7

1.81

1.72

mmol/l

1.39

957

1988

Invasive ventilation

313

369

9.37

248.57

2.8

1.9

1.81

1.72

mmol/l

0.53

280

362

Other diseases of pleura

982

2648

3.35

247.49

2.7

1.8

1.68

1.76

mmol/l

1.56

966

2580

Cardiovascular diseases (excluding rheumatic etc)

873

1284

3.97

247.33

2.0

1.6

1.71

1.80

mmol/l

1.11

850

1261

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1557

3875

2.66

244.80

2.2

1.7

1.64

1.79

mmol/l

6.87

1536

3761

Cardiac arrhythmias

846

1437

3.89

244.34

2.0

1.5

1.64

1.71

mmol/l

0.93

823

1411

Oral corticosteroids

1731

4126

2.53

239.99

2.1

1.7

1.66

1.78

mmol/l

4.81

1702

4013

First line medication for Crohn's disease

1738

3731

2.55

239.45

2.1

1.7

1.69

1.80

mmol/l

3.35

1709

3629

Dialysis, with operation codes

397

638

6.64

237.90

3.4

1.7

1.36

1.76

mmol/l

12.79

392

624

Pain in throat and chest

1281

2653

2.94

237.00

2.0

1.7

1.68

1.83

mmol/l

4.49

1264

2572

Heart failure and coronary heart disease

914

1881

3.55

236.38

2.5

1.8

1.70

1.75

mmol/l

0.68

898

1830

Any gastric operation

1128

1755

3.27

231.78

2.1

1.5

1.66

1.83

mmol/l

4.98

1106

1704

GASTRO-related operations

1128

1755

3.27

231.78

2.1

1.5

1.66

1.83

mmol/l

4.98

1106

1704

Erysipelas

1186

3174

2.90

229.40

2.2

1.6

1.73

1.75

mmol/l

0.40

1161

3101

Asthma, unspecified (mode), excluding more controls

757

1483

3.89

229.40

2.1

1.4

1.67

1.88

mmol/l

5.15

734

1436

Nephropathy related operations

401

683

6.29

226.98

3.5

1.9

1.36

1.72

mmol/l

11.14

396

667

ILD medications: prednisolone, methylprednisolone, prednisone

1727

3952

2.48

226.61

2.2

1.7

1.65

1.81

mmol/l

7.12

1695

3843

Syncope and collapse

778

1866

3.65

223.97

2.0

1.7

1.75

1.73

mmol/l

0.14

761

1813

COPD (mode)

597

1061

4.55

223.15

2.4

1.5

1.61

1.83

mmol/l

5.06

587

1029

Concussion

833

2001

3.46

219.23

2.1

1.7

1.77

1.71

mmol/l

0.72

815

1969

Hypo-osmolality and hyponatraemia

484

1002

5.04

218.00

2.5

1.6

1.71

1.68

mmol/l

0.21

475

973

Acute bronchitis

838

2521

3.35

217.94

2.5

1.8

1.61

1.74

mmol/l

3.62

820

2462

Atrial fibrillation and flutter with reimbursement

437

436

6.55

217.52

2.3

1.5

1.68

1.81

mmol/l

1.04

422

428

Cerebrovascular diseases (FINNGEN)

476

612

5.63

216.75

2.1

1.5

1.83

1.78

mmol/l

0.28

449

603

Metabolic disorders

1486

3612

2.55

211.44

2.3

1.7

1.76

1.73

mmol/l

0.35

1462

3514

Bronchitis

1680

4497

2.39

210.28

2.2

1.7

1.63

1.79

mmol/l

8.80

1646

4383

Other acute lower respiratory infections

994

3283

2.95

207.96

2.4

1.8

1.62

1.75

mmol/l

4.43

973

3205

Valvular heart disease excluding rheumatic fever

800

1683

3.51

206.45

2.0

1.7

1.71

1.75

mmol/l

0.47

781

1644

Substance abuse, excluding more controls

972

2811

3.01

205.42

2.3

1.7

1.98

1.71

mmol/l

6.65

955

2743

Codes for special purposes

980

3411

2.93

205.15

2.4

1.8

1.61

1.75

mmol/l

4.02

954

3337

Provisional assignment of new diseases of uncertain etiology

979

3406

2.93

205.10

2.4

1.8

1.61

1.75

mmol/l

4.07

953

3332

Symptoms and signs involving the circulatory and respiratory systems

1426

2741

2.64

204.92

2.0

1.7

1.72

1.83

mmol/l

2.92

1402

2658

Asthma, unspecified (mode)

785

1725

3.49

204.24

2.1

1.5

1.67

1.87

mmol/l

5.61

762

1674

Diseases of arteries, arterioles and capillaries (FINNGEN)

401

445

6.40

203.90

2.4

1.5

1.62

1.83

mmol/l

2.32

393

436

Non-rheumatic valve diseases

790

1673

3.48

201.61

2.0

1.7

1.71

1.75

mmol/l

0.40

772

1634

Ischemic heart diseases

1279

2906

2.69

200.66

2.1

1.8

1.69

1.76

mmol/l

1.59

1251

2828

Heart failure and bmi 25plus

807

1630

3.46

197.30

2.5

1.7

1.70

1.75

mmol/l

0.81

796

1585

Inflammatory bowel disease treatment related agents

1737

4254

2.31

196.85

2.1

1.7

1.68

1.78

mmol/l

3.39

1706

4139

Erysipelas

946

2906

2.94

193.72

2.3

1.6

1.73

1.75

mmol/l

0.24

928

2838

Persons encountering health services in other circumstances, wide

1761

3983

2.30

193.24

2.2

1.7

1.72

1.76

mmol/l

0.72

1717

3894

Pulmonary heart disease, diseases of pulmonary circulation

695

2067

3.47

191.55

2.3

1.8

1.67

1.72

mmol/l

0.72

684

2015

Adjustment and management of implanted device

453

1002

4.72

189.66

2.0

1.7

1.64

1.74

mmol/l

1.50

444

975

Asthma, excluding more controls

960

1610

3.15

189.60

2.1

1.4

1.67

1.89

mmol/l

6.22

935

1559

Aplastic and other anaemias

909

2946

2.95

188.66

2.5

1.8

1.68

1.73

mmol/l

0.84

887

2878

ILD medications

1687

4022

2.30

187.60

2.2

1.7

1.65

1.80

mmol/l

6.92

1656

3912

Hard cardiovascular diseases

1252

2905

2.61

185.63

2.0

1.8

1.72

1.74

mmol/l

0.27

1218

2838

Cardiovascular diseases

762

1154

3.60

184.90

2.0

1.6

1.71

1.83

mmol/l

1.62

743

1132

Viral pneumonia

328

561

6.13

183.87

2.8

1.6

1.60

1.79

mmol/l

2.77

322

544

Hypertension, essential

1072

2171

2.84

182.64

2.0

1.6

1.69

1.76

mmol/l

1.22

1046

2120

Mental and behavioural disorders due to psychoactive substance use

1028

3597

2.70

181.60

2.3

1.8

1.98

1.71

mmol/l

7.48

1010

3513

Insulin medication

1040

3303

2.70

179.75

2.5

1.7

1.80

1.70

mmol/l

2.37

1014

3227

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

552

825

4.29

178.97

2.0

1.5

1.69

1.76

mmol/l

0.82

543

812

Pulmonary embolism

636

1880

3.49

177.08

2.2

1.8

1.67

1.71

mmol/l

0.56

627

1838

Headache

879

2433

2.93

175.40

2.1

1.6

1.65

1.73

mmol/l

1.59

867

2368

Intracranial injury

1003

3609

2.68

175.36

2.1

1.8

1.81

1.74

mmol/l

0.99

973

3528

Other and unspecified anaemias

837

2769

2.96

175.22

2.5

1.8

1.69

1.73

mmol/l

0.65

817

2706

Pulmonary heart disease

636

1893

3.47

175.17

2.2

1.8

1.67

1.71

mmol/l

0.56

627

1851

Type 2 diabetes, wide definition

1234

3177

2.53

174.84

2.3

1.7

1.84

1.67

mmol/l

6.49

1204

3102

Any reimbursement code in KELA

691

927

3.78

174.45

2.1

1.4

1.68

1.79

mmol/l

1.10

679

898

Other anaemias

839

2781

2.94

174.09

2.5

1.8

1.69

1.73

mmol/l

0.68

819

2716

Hypertensive diseases

1076

2244

2.74

172.85

2.1

1.6

1.70

1.76

mmol/l

0.93

1049

2192

Tramadol

1150

2744

2.61

172.51

2.0

1.7

1.70

1.76

mmol/l

0.95

1124

2668

Hypertension

1074

2242

2.74

172.15

2.0

1.6

1.70

1.76

mmol/l

0.91

1047

2190

Oxycodone

705

2014

3.24

171.38

2.3

1.8

1.72

1.76

mmol/l

0.39

693

1956

Venous thromboembolism

956

3484

2.71

171.00

2.1

1.8

1.67

1.74

mmol/l

1.24

937

3403

Bleeding

1327

4030

2.38

170.16

2.2

1.8

1.76

1.73

mmol/l

0.37

1269

3966

Asthma

1005

1868

2.86

169.39

2.1

1.5

1.67

1.89

mmol/l

7.07

977

1813

1028

3521

2.62

169.27

2.3

1.8

2.00

1.71

mmol/l

8.53

1010

3437

Percutaneous Coronary Intervention

1168

2831

2.57

169.22

2.1

1.8

1.68

1.76

mmol/l

1.67

1146

2754

Non-ischemic cardiomyopathy

577

1275

3.75

168.70

2.3

1.6

1.67

1.74

mmol/l

0.96

566

1240

Poisoning by medicine

445

1065

4.31

167.88

2.6

1.8

1.86

1.70

mmol/l

1.41

436

1042

996

3472

2.64

167.76

2.3

1.8

2.02

1.71

mmol/l

9.26

978

3389

Mental and behavioural disorders due to alcohol

897

3179

2.77

167.58

2.3

1.8

2.05

1.72

mmol/l

9.07

880

3105

Coronary revascularization (ANGIO or CABG)

1165

2831

2.56

167.46

2.1

1.8

1.68

1.76

mmol/l

1.69

1143

2754

Certain infectious and parasitic diseases

1340

2777

2.44

165.85

2.1

1.5

1.71

1.80

mmol/l

1.92

1313

2706

Other pulmonary diagnosis

1037

1882

2.79

165.62

1.9

1.5

1.66

1.89

mmol/l

7.84

1015

1827

Benzodiazepine use

1517

4762

2.22

165.36

2.1

1.8

1.74

1.75

mmol/l

0.17

1488

4643

DVT of lower extremities and pulmonary embolism

790

2758

2.92

164.03

2.2

1.8

1.68

1.72

mmol/l

0.47

776

2691

1636

3876

2.21

162.81

2.1

1.7

1.64

1.80

mmol/l

8.29

1604

3776

Substance abuse

972

3557

2.61

161.94

2.3

1.8

1.98

1.72

mmol/l

6.74

955

3475

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

464

1169

4.04

161.67

2.5

1.6

1.80

1.65

mmol/l

1.95

456

1144

Poisoning by drugs, medicaments and biological substances

467

1192

4.03

161.35

2.6

1.8

1.84

1.71

mmol/l

1.11

458

1166

Excluding asthma or asthma-COPD overlap

1021

1882

2.75

158.61

1.9

1.5

1.66

1.89

mmol/l

7.54

999

1827

Asthma (only as main-diagnosis), excluding more controls

836

1610

3.00

158.39

2.1

1.4

1.63

1.89

mmol/l

8.24

813

1559

Other diseases of the respiratory system

484

1290

3.90

157.94

3.2

1.8

1.62

1.72

mmol/l

1.44

476

1262

Other respiratory disorders and diseases

484

1290

3.90

157.94

3.2

1.8

1.62

1.72

mmol/l

1.44

476

1262

Paroxysmal tachycardia

334

526

5.43

157.36

2.0

1.5

1.72

1.77

mmol/l

0.32

325

518

Any death

1049

2995

2.56

156.61

2.3

1.7

1.88

1.68

mmol/l

5.52

1006

2938

Major coronary heart disease event

1242

3170

2.40

155.77

2.1

1.8

1.68

1.76

mmol/l

1.78

1217

3085

Parasetamol

1015

1914

2.72

155.08

2.0

1.8

1.73

1.82

mmol/l

1.33

995

1870

Codeine

1282

2951

2.39

154.98

1.9

1.7

1.75

1.78

mmol/l

0.34

1255

2871

Insulin, combination of fast acting with intermediate-acting or long-acting

1041

3905

2.48

154.39

2.5

1.8

1.80

1.73

mmol/l

1.17

1015

3815

Diarrhoea and gastroenteritis of presumed infectious origin

1108

4215

2.40

153.51

2.5

1.7

1.70

1.76

mmol/l

1.18

1084

4119

COPD differential diagnosis

1008

1880

2.72

153.30

1.9

1.5

1.65

1.88

mmol/l

7.99

986

1825

ILD differential diagnosis

1008

1880

2.72

153.29

1.9

1.5

1.65

1.88

mmol/l

7.99

986

1825

Sleep apnoea

1382

4042

2.24

151.88

2.1

1.8

1.73

1.75

mmol/l

0.29

1362

3934

Injuries to the head

1605

4731

2.11

150.02

2.1

1.8

1.79

1.73

mmol/l

1.10

1568

4619

Ischaemic heart disease, wide definition

1157

3010

2.42

148.51

2.0

1.8

1.70

1.76

mmol/l

0.96

1132

2937

Early onset COPD, excluding more controls

347

753

4.73

147.93

2.4

1.5

1.58

1.90

mmol/l

6.87

340

729

ILD medications: immunosuppressive drugs

934

3461

2.54

147.46

2.3

1.7

1.61

1.80

mmol/l

6.68

917

3371

Glomerular diseases

422

1076

4.08

146.73

3.2

1.9

1.43

1.73

mmol/l

11.95

413

1053

Other CVD (FINNGEN)

231

238

7.81

146.05

2.5

1.4

1.62

1.84

mmol/l

1.52

225

231

Insulin, fast-acting

669

2289

2.99

145.22

2.7

1.8

1.71

mmol/l

0.03

654

2238

Insulin, intermediate and long-acting

935

3678

2.52

144.88

2.5

1.8

1.81

1.73

mmol/l

1.62

912

3590

Coronary atherosclerosis

967

2398

2.59

144.17

2.1

1.7

1.72

1.77

mmol/l

0.81

948

2335

Other arrhythmias

844

2389

2.70

143.44

1.8

1.7

1.61

1.75

mmol/l

3.70

828

2337

Emergency coronary revascularization (for ACS)

1263

3402

2.29

143.06

2.1

1.8

1.69

1.75

mmol/l

1.43

1240

3310

Sleep apnoea, including avohilmo

1418

4106

2.17

141.73

2.1

1.8

1.73

1.76

mmol/l

0.49

1399

3994

Other antidepressants

1479

3528

2.17

141.64

2.1

1.8

1.74

1.75

mmol/l

0.11

1454

3431

Nausea and vomiting

510

1475

3.47

141.25

2.6

1.8

1.70

1.72

mmol/l

0.16

502

1440

Pacemaker

656

2169

2.98

139.45

2.1

1.9

1.66

1.71

mmol/l

0.82

646

2109

Oedema, not elsewhere classified

500

1452

3.47

139.10

2.3

1.6

1.64

1.71

mmol/l

0.93

488

1411

Intestinal infectious diseases

1377

4962

2.13

138.73

2.4

1.7

1.71

1.76

mmol/l

1.00

1348

4845

Mental and behavioural disorders due to alcohol, excluding acute intoxication

764

2867

2.71

137.85

2.4

1.8

2.05

1.72

mmol/l

7.19

749

2801

Diabetes mellitus

1413

3882

2.15

137.22

2.1

1.7

1.80

1.69

mmol/l

3.70

1381

3790

Opioids

1294

3007

2.26

136.69

1.9

1.7

1.71

1.77

mmol/l

1.21

1269

2926

Alcohol use disorder, Swedish definition

903

3370

2.50

136.54

2.4

1.8

2.00

1.72

mmol/l

6.67

887

3289

Diabetes, varying definitions

1403

3886

2.14

134.63

2.1

1.7

1.81

1.69

mmol/l

3.76

1371

3794

Asthma (only as main-diagnosis)

858

1868

2.69

134.36

2.1

1.5

1.63

1.89

mmol/l

9.17

835

1813

Asthma (mode)

914

1880

2.63

134.16

2.0

1.5

1.66

1.88

mmol/l

7.08

891

1825

Insulin, fast-acting or short human

672

2407

2.86

134.10

2.7

1.8

1.71

1.73

mmol/l

0.24

657

2351

Alcohol use disorder, ICD-based

711

2634

2.76

133.06

2.3

1.8

2.06

1.73

mmol/l

7.09

698

2571

Disorders of other endocrine glands

722

2659

2.72

131.73

2.4

1.8

1.66

1.70

mmol/l

0.56

706

2599

Acute upper respiratory infections of multiple and unspecified sites

1094

3589

2.29

130.43

2.2

1.8

1.62

1.78

mmol/l

7.31

1069

3500

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1308

3689

2.16

129.42

2.2

1.7

1.86

1.68

mmol/l

7.25

1278

3601

Type 2 diabetes

1335

3696

2.13

127.05

2.1

1.7

1.81

1.68

mmol/l

4.58

1303

3608

Abnormalities of heart beat

524

1649

3.17

126.34

1.9

1.7

1.62

1.76

mmol/l

3.13

516

1597

Endocrine, nutritional and metabolic diseases

1017

2135

2.44

125.99

2.1

1.5

1.76

1.74

mmol/l

0.24

998

2076

Glomerular disorders in diseases classified elsewhere

296

649

4.79

125.78

3.2

1.8

1.39

1.73

mmol/l

10.79

290

634

Complications of surgical and medical care, not elsewhere classified

1401

4722

2.06

125.67

2.2

1.8

1.62

1.77

mmol/l

7.09

1372

4604

COPD

781

2513

2.59

123.94

2.4

1.8

1.64

1.78

mmol/l

3.41

766

2447

STROKE

726

1839

2.72

121.75

2.0

1.6

1.80

1.73

mmol/l

0.89

693

1805

Episodal and paroxysmal disorders

1465

3670

2.05

121.62

2.0

1.8

1.76

1.73

mmol/l

0.50

1430

3578

Diabetes, insulin treatment (Kela reimbursement)

1391

4137

2.05

120.97

2.2

1.7

1.86

1.69

mmol/l

7.31

1359

4039

Myocardial infarction

753

2036

2.65

120.38

2.2

1.8

1.77

1.79

mmol/l

0.17

738

1983

Conduction disorders

475

1166

3.37

120.05

2.3

1.7

1.69

1.73

mmol/l

0.37

466

1138

Major coronary heart disease event excluding revascularizations

901

2511

2.43

119.25

2.2

1.8

1.74

1.77

mmol/l

0.33

884

2443

Suicide or other Intentional self-harm

428

1276

3.44

117.50

2.5

1.8

1.80

1.70

mmol/l

0.94

421

1250

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

464

1453

3.26

117.43

2.5

1.8

1.80

1.71

mmol/l

0.92

456

1423

Asthma-related infections

908

3917

2.30

116.37

2.2

1.8

1.62

1.76

mmol/l

5.18

884

3832

Asthma, hospital admission 2, infections

908

3917

2.30

116.37

2.2

1.8

1.62

1.76

mmol/l

5.18

884

3832

Other chronic obstructive pulmonary disease

741

2423

2.57

115.93

2.5

1.8

1.62

1.77

mmol/l

4.02

726

2360

Codeine or tramadol medication

1526

4278

1.97

115.92

1.9

1.8

1.73

1.75

mmol/l

0.26

1491

4174

Hyperlipidaemia, other/unspecified

661

2311

2.69

115.83

2.0

1.7

1.75

1.72

mmol/l

0.35

648

2243

Later onset COPD, excluding more controls

366

729

3.99

115.44

2.5

1.5

1.63

1.77

mmol/l

1.59

360

708

Pain in limb

1171

3750

2.11

112.55

2.1

1.8

1.68

1.79

mmol/l

3.30

1152

3657

Iron deficiency anaemia

696

2728

2.56

112.46

2.5

1.8

1.69

1.71

mmol/l

0.28

683

2667

692

2736

2.55

111.34

2.2

1.8

1.60

1.74

mmol/l

4.66

673

2676

Problems related to lifestyle

223

427

5.42

110.68

2.7

1.6

1.76

1.75

mmol/l

0.05

218

419

Constipation

1249

4281

2.04

110.60

2.2

1.8

1.68

1.75

mmol/l

1.51

1229

4166

Hernia of abdominal wall, postoperative

278

645

4.41

109.10

2.2

1.5

1.67

1.82

mmol/l

1.30

273

628

Other disorders of urethra and urinary system

973

3184

2.23

109.08

2.2

1.8

1.66

1.75

mmol/l

2.00

953

3105

COPD, hospital admission 2, with asthma infections

593

1871

2.78

108.94

2.6

1.8

1.62

1.74

mmol/l

2.65

582

1828

Cardiodefibrillation

642

2511

2.61

107.68

2.0

1.9

1.72

mmol/l

0.03

629

2450

Diarrhoea and gastroenteritis of presumed infectious origin

1375

4693

1.95

106.14

2.3

1.8

1.70

1.76

mmol/l

1.44

1343

4580

All influenza

400

1218

3.36

106.03

2.8

1.6

1.55

1.81

mmol/l

7.22

394

1187

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

439

1398

3.19

105.94

1.7

1.9

1.82

1.72

mmol/l

1.04

431

1370

Other soft tissue disorders, not elsewhere classified

1302

3849

2.00

105.34

2.0

1.8

1.69

1.79

mmol/l

2.85

1282

3755

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

390

499

3.96

104.94

2.0

1.6

1.69

1.81

mmol/l

1.11

385

480

Polyarthropathies

973

2905

2.22

104.49

2.2

1.8

1.70

1.79

mmol/l

1.79

959

2825

Other chronic obstructive pulmonary disease, including avohilmo

849

3105

2.30

104.36

2.3

1.8

1.64

1.74

mmol/l

2.32

829

3027

Nutritional anaemias

774

3220

2.36

104.00

2.5

1.8

1.70

1.71

mmol/l

0.06

759

3144

Other respiratory diseases principally affecting the interstitium

382

1153

3.43

103.42

2.4

1.9

1.66

1.72

mmol/l

0.56

374

1126

Diabetes medication

1350

4124

1.96

103.14

2.2

1.7

1.84

1.69

mmol/l

5.42

1320

4023

Pleural effusion

321

868

3.83

102.73

2.5

1.8

1.67

1.75

mmol/l

0.55

315

843

Abnormal spermatozoa

294

752

4.10

102.32

1.9

2.0

1.81

1.74

mmol/l

0.38

287

733

COPD, early/later onset

748

2680

2.40

101.41

2.4

1.8

1.63

1.75

mmol/l

2.82

733

2616

Intestinal infectious diseases

1529

4706

1.87

101.32

2.2

1.8

1.70

1.76

mmol/l

1.24

1497

4591

COPD, hospital admissions

742

2665

2.40

100.82

2.5

1.8

1.64

1.75

mmol/l

2.62

727

2602

Neurological diseases

1093

2594

2.14

100.59

2.0

1.7

1.72

1.76

mmol/l

0.42

1072

2528

Other interstitial pulmonary diseases

336

956

3.65

99.88

2.3

1.9

1.64

1.73

mmol/l

0.84

330

932

Interstitial lung disease endpoints

336

962

3.63

98.95

2.3

1.9

1.64

1.74

mmol/l

0.92

330

937

Interstitial lung disease

336

962

3.63

98.95

2.3

1.9

1.64

1.74

mmol/l

0.92

330

937

COPD related to multimorbidity

669

2315

2.49

98.51

2.5

1.8

1.63

1.75

mmol/l

2.56

654

2263

Haemorrhage from respiratory passages

503

1621

2.85

98.44

2.2

1.7

1.64

1.80

mmol/l

3.37

493

1569

Hyperkalaemia

175

301

6.19

98.23

3.2

1.6

1.57

1.65

mmol/l

0.56

169

293

Sleep disorders (combined)

1473

4132

1.89

97.94

2.0

1.8

1.71

1.76

mmol/l

0.92

1443

4022

Any mental disorder

1416

3737

1.91

96.92

2.1

1.7

1.79

1.70

mmol/l

2.37

1388

3645

Mood disorders, excluding more controls

1198

3613

2.00

96.91

2.2

1.7

1.77

1.70

mmol/l

1.24

1173

3522

ILD, hospital admissions

330

949

3.61

96.55

2.3

1.9

1.64

1.73

mmol/l

0.90

324

924

Other diseases of urinary system

1316

3850

1.94

96.37

2.0

1.8

1.68

1.77

mmol/l

2.17

1288

3754

COPD, hospital admissions 3, with asthma pneumonia sepsis

508

1575

2.83

95.90

2.7

1.9

1.62

1.75

mmol/l

2.17

501

1538

Antihypertensive medication - note that there are other indications

682

1419

2.57

95.90

2.1

1.5

1.68

1.76

mmol/l

1.12

670

1385

Type 2 diabetes, definitions combined

1204

3597

1.98

95.10

2.0

1.7

1.89

1.68

mmol/l

9.23

1175

3511

Type 2 diabetes, strict (exclude DM1)

1212

3637

1.98

94.57

2.0

1.7

1.89

1.67

mmol/l

9.52

1183

3551

Symptoms and signs involving the digestive system and abdomen

1304

3378

1.95

94.42

2.0

1.8

1.71

1.78

mmol/l

1.12

1282

3290

Schizophrenia or delusion, excluding more controls

430

1448

2.99

94.15

2.6

1.6

1.73

1.66

mmol/l

0.68

422

1415

Abdominal and pelvic pain

1298

3378

1.95

93.50

2.0

1.8

1.72

1.78

mmol/l

1.04

1273

3290

Fall on same level

1466

4364

1.85

92.62

2.1

1.8

1.76

1.75

mmol/l

0.17

1434

4261

Neurological diseases, wide definition

365

491

3.78

92.50

2.0

1.5

1.75

1.80

mmol/l

0.24

358

481

Diseases of the respiratory system

752

1573

2.42

91.72

2.0

1.5

1.65

1.87

mmol/l

6.35

733

1530

Chronic lower respiratory diseases

1547

4584

1.81

91.05

2.1

1.8

1.64

1.79

mmol/l

7.12

1515

4471

Asthma-related pneumonia

598

2451

2.48

90.69

2.5

1.8

1.62

1.73

mmol/l

2.80

583

2396

Asthma-related pneumonia or sepsis

598

2452

2.48

90.59

2.5

1.8

1.62

1.73

mmol/l

2.80

583

2397

Asthma, hospital admissions 3, pneumonia

598

2452

2.48

90.59

2.5

1.8

1.62

1.73

mmol/l

2.80

583

2397

Other and unspecified iron deficiency

538

2105

2.60

90.34

2.6

1.8

1.67

1.68

mmol/l

0.16

528

2059

Gout

495

1615

2.76

90.30

2.4

1.9

1.69

1.78

mmol/l

1.32

489

1568

Other diseases of blood and blood-forming organs, wide

397

1340

3.04

88.88

2.3

1.9

1.71

mmol/l

0.01

384

1311

Persons encountering health services for specific procedures, not carried out

184

363

5.28

88.50

2.7

1.6

1.62

1.72

mmol/l

0.53

184

353

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

931

4105

2.06

88.39

2.2

1.8

1.64

1.75

mmol/l

2.76

911

4002

Obesity related asthma

520

2028

2.61

88.02

2.4

1.8

1.68

1.72

mmol/l

0.40

511

1983

Angina pectoris

751

2214

2.29

87.83

2.0

1.7

1.68

1.77

mmol/l

1.72

740

2154

AV-block

298

728

3.68

87.61

2.3

1.7

1.66

1.69

mmol/l

0.17

291

709

Certain infectious and parasitic diseases

886

2042

2.19

86.92

2.1

1.5

1.70

1.79

mmol/l

1.49

868

1995

Alcohol dependence

445

1616

2.81

86.90

2.4

1.8

2.08

1.74

mmol/l

3.98

439

1578

Acute alcohol intoxication

431

1542

2.86

86.56

2.6

1.9

2.09

1.73

mmol/l

6.68

426

1508

Type 2 diabetes, definitions combined, including avohilmo

1183

3607

1.93

85.98

2.0

1.7

1.89

1.67

mmol/l

9.18

1155

3524

Explicit bacterial Sepsis

206

461

4.62

85.08

2.9

1.6

1.71

1.70

mmol/l

0.03

201

453

Diseases of the digestive system

707

3191

2.24

85.07

2.4

1.8

1.82

1.71

mmol/l

1.82

687

3123

Anxiety disorders, excluding more controls

1003

3280

2.01

84.11

2.2

1.7

1.80

1.69

mmol/l

2.22

983

3201

Retention of urine

574

1931

2.49

83.98

2.2

1.9

1.68

1.77

mmol/l

1.30

559

1883

Spondylosis

786

3005

2.16

83.57

2.0

1.9

1.68

1.76

mmol/l

1.49

770

2930

Epilepsy

462

1741

2.69

83.19

2.2

1.8

2.16

1.71

mmol/l

8.04

448

1703

Liquid cancers, helper endpoint

567

2039

2.47

82.89

2.2

1.9

1.70

1.74

mmol/l

0.46

549

1994

Exclusions for E4_PCOS_BROAD

306

937

3.35

80.72

2.6

1.9

1.71

1.67

mmol/l

0.38

298

916

Depression or dysthymia

850

2217

2.14

80.51

1.9

1.7

1.78

1.71

mmol/l

1.04

829

2152

Other nutritional deficiencies

841

3904

2.05

80.39

2.4

1.8

1.76

1.72

mmol/l

0.56

825

3808

Open wound of head

760

3487

2.13

80.27

2.1

1.8

1.79

1.74

mmol/l

0.58

743

3405

Use of hypnotics and sedatives

1358

4360

1.80

80.24

2.1

1.8

1.72

1.75

mmol/l

0.60

1330

4253

Disorders of gallbladder, biliary tract and pancreas

1263

4390

1.83

79.93

2.0

1.8

1.73

mmol/l

0.00

1228

4287

Other reaction to severe stress, and adjustment disorders

477

1874

2.58

79.36

2.2

1.7

1.71

1.69

mmol/l

0.19

463

1831

Symptoms and signs involving the urinary system

1032

4131

1.92

79.02

2.1

1.8

1.66

1.75

mmol/l

2.12

1003

4037

Obesity due to excess calories

627

2793

2.28

78.85

2.3

1.8

1.74

1.70

mmol/l

0.42

617

2728

ILD, hospital admissions 1, main diag only

283

844

3.48

78.35

2.3

1.9

1.66

1.72

mmol/l

0.44

277

821

Complications of procedures, not elsewhere classified

1040

4569

1.90

78.34

2.2

1.8

1.64

1.77

mmol/l

4.51

1018

4455

Traumatic subdural haemorrhage

254

672

3.73

78.10

2.0

1.8

1.83

1.70

mmol/l

0.85

240

658

Low back pain

985

3657

1.95

78.02

2.1

1.8

1.70

1.77

mmol/l

1.58

964

3566

Type 1 diabetes, wide definition, subgroup 1

318

1018

3.19

77.67

2.7

1.8

1.57

1.68

mmol/l

1.44

313

997

Myocardial infarction, strict

628

1949

2.33

77.38

2.3

1.8

1.77

1.78

mmol/l

0.07

613

1899

Streptococcal septicaemia

184

407

4.70

77.32

2.9

1.6

1.68

1.70

mmol/l

0.10

179

395

Dipeptidyl peptidase 4 (DPP-4) inhibitors

780

3016

2.10

76.73

2.2

1.8

1.95

1.67

mmol/l

9.96

762

2942

Gout, FINNGEN

495

2025

2.49

75.55

2.4

1.8

1.69

1.75

mmol/l

0.77

489

1977

Acute upper respiratory infections

1301

4537

1.78

75.03

2.1

1.8

1.64

1.78

mmol/l

4.47

1271

4423

Disorders of lens

866

2682

2.04

74.80

2.2

1.8

1.67

1.79

mmol/l

2.79

846

2611

Mood [affective] disorders

1279

4692

1.78

74.62

2.2

1.8

1.75

1.74

mmol/l

0.16

1250

4582

Mood disorders

1281

4697

1.78

74.42

2.2

1.8

1.75

1.74

mmol/l

0.16

1251

4588

Psychiatric diseases

1200

3280

1.85

74.08

2.0

1.7

1.77

1.70

mmol/l

1.20

1175

3197

Selective serotonin reuptake inhibitors

1232

3554

1.82

73.95

2.0

1.8

1.76

1.74

mmol/l

0.20

1210

3457

Other disorders of bladder

238

659

3.74

73.75

1.9

1.70

1.68

mmol/l

0.10

231

648

Delirium, not induced by alcohol and other psychoactive substances

259

757

3.54

73.74

2.7

1.9

1.72

1.68

mmol/l

0.24

251

740

Personality disorders, excluding more controls

321

1065

3.06

73.68

2.6

1.6

1.82

1.66

mmol/l

1.37

316

1041

Pain, not elsewhere classified

337

1153

2.97

73.27

2.2

1.6

1.70

1.71

mmol/l

0.05

332

1121

Osteopathies and chondropathies

761

3487

2.06

73.26

2.3

1.8

1.60

1.74

mmol/l

4.08

748

3405

Symptoms and signs involving cognition, perception, emotional state and behaviour

1225

4712

1.79

73.05

2.2

1.8

1.73

1.74

mmol/l

0.13

1196

4602

Diseases of arteries, arterioles and capillaries

928

3566

1.95

72.91

2.3

1.8

1.67

1.75

mmol/l

1.56

905

3480

Autoimmune diseases excluding thyroid diseases

1290

3993

1.78

71.87

2.1

1.8

1.68

1.79

mmol/l

3.23

1267

3891

Other external causes of accidental injury

963

2477

1.96

71.23

2.0

1.7

1.70

1.74

mmol/l

0.48

943

2414

Other functional intestinal disorders

639

2762

2.18

71.00

2.3

1.8

1.67

1.73

mmol/l

0.80

629

2689

Complications of medical and surgical care

954

4708

1.88

70.88

2.2

1.8

1.61

1.75

mmol/l

5.30

934

4593

Used for control exclusion in common control thyroid runs

1302

3739

1.77

70.67

2.0

1.8

1.70

1.80

mmol/l

2.47

1281

3643

Autoimmune diseases

1365

4010

1.74

70.26

2.1

1.8

1.73

1.79

mmol/l

1.20

1342

3908

Other (not insulin) diabetes medications

1174

3891

1.81

70.24

2.1

1.7

1.90

1.68

mmol/l

9.65

1147

3796

Symptoms and signs involving the nervous and musculoskeletal systems

783

3969

2.00

70.10

2.3

1.8

1.70

1.72

mmol/l

0.23

767

3875

Type 1 diabetes

364

1330

2.78

70.01

2.8

1.7

1.55

1.67

mmol/l

1.72

356

1303

GI-bleeding

516

2231

2.36

69.92

2.4

1.9

1.83

1.73

mmol/l

1.30

499

2182

Obesity

774

3774

2.00

69.44

2.4

1.8

1.74

1.72

mmol/l

0.27

757

3681

Type 1 diabetes, wide definition

324

1118

2.95

69.42

2.8

1.8

1.57

1.68

mmol/l

1.57

319

1096

Other diseases of the digestive system

513

2221

2.35

69.33

2.4

1.9

1.84

1.72

mmol/l

1.41

496

2175

Autoimmune diseases excluding thyroid diseases, strict definition

1242

3858

1.78

69.30

2.1

1.8

1.67

1.79

mmol/l

3.73

1221

3762

Accidents

955

2477

1.95

69.01

2.0

1.7

1.70

1.74

mmol/l

0.58

934

2414

Depression

1162

4449

1.78

68.92

2.2

1.8

1.76

1.74

mmol/l

0.24

1136

4345

Diabetic maculopathy, excluding more controls

209

555

3.89

68.79

2.7

1.8

1.58

1.63

mmol/l

0.36

203

547

Malignant neoplasm

1020

3248

1.87

68.69

1.9

1.74

mmol/l

0.00

996

3175

Myocardial infarction, without ST-elevation

626

2673

2.17

68.56

2.3

1.9

1.71

1.74

mmol/l

0.25

613

2607

Obesity and other hyperalimentation

776

3800

1.99

68.48

2.4

1.8

1.75

1.72

mmol/l

0.31

759

3707

Cardiomyopathy

257

788

3.33

67.68

2.2

1.7

1.71

1.74

mmol/l

0.18

252

772

Kela-code for severe mental illness

495

2132

2.36

67.54

2.4

1.8

1.74

1.73

mmol/l

0.06

484

2085

Infections of the skin and subcutaneous tissue

763

3853

1.98

67.10

2.3

1.8

1.71

1.76

mmol/l

0.61

750

3766

Unspecified fall

700

3427

2.04

66.30

2.1

1.9

1.83

1.71

mmol/l

2.01

688

3349

Diseases of liver

505

2216

2.32

66.13

2.5

1.8

1.84

1.71

mmol/l

1.97

493

2165

Cough

473

1899

2.38

65.89

2.1

1.7

1.57

1.78

mmol/l

5.83

461

1843

Falls/tendency to fall

1280

3702

1.74

65.68

2.1

1.8

1.75

1.74

mmol/l

0.12

1251

3612

Cystitis

1025

3342

1.84

65.21

2.0

1.8

1.64

1.75

mmol/l

3.20

1006

3257

Anxiety (asthma-related co-morbidities)

669

2511

2.08

64.34

2.2

1.7

1.79

1.69

mmol/l

1.49

657

2453

Chronic apical periodontitis

1368

4652

1.69

64.31

1.9

1.8

1.74

1.75

mmol/l

0.07

1336

4542

Early onset COPD

347

1298

2.73

64.22

2.4

1.8

1.58

1.77

mmol/l

4.15

340

1264

Malignant neoplasm, wide definition for exclusion

1028

3327

1.83

63.88

1.9

1.8

1.73

1.74

mmol/l

0.09

1006

3248

Anxiety disorders

1066

4196

1.78

63.70

2.2

1.8

1.78

1.72

mmol/l

0.99

1043

4093

Genitourinary diseases

709

1701

2.11

63.48

2.1

1.6

1.68

1.90

mmol/l

5.67

696

1665

Other symptoms and signs involving the nervous and musculoskeletal systems

563

2626

2.17

63.33

2.2

1.8

1.67

1.72

mmol/l

0.49

551

2564

Unspecified mental disorder

524

2377

2.23

63.14

2.4

1.8

1.74

mmol/l

0.03

513

2327

Other CVD

350

1333

2.69

62.61

2.3

1.9

1.62

1.71

mmol/l

0.98

343

1304

Diagnoses used for exclusion with ILD

406

1664

2.49

62.18

2.4

1.9

1.72

1.73

mmol/l

0.10

399

1627

Neurotic, stress-related and somatoform disorders

1049

4160

1.78

62.03

2.2

1.8

1.78

1.72

mmol/l

1.03

1026

4058

Spondylopathies

996

3289

1.83

61.96

1.9

1.8

1.71

1.77

mmol/l

1.01

974

3206

Asthma (diagnoses ohter than nonallergic)

1077

5166

1.74

61.37

2.1

1.8

1.65

1.76

mmol/l

3.49

1046

5046

Senile cataract

776

2437

1.97

61.12

2.2

1.8

1.69

1.78

mmol/l

1.52

758

2373

Any event in cancer register

1067

3557

1.78

61.07

1.8

1.9

1.75

1.73

mmol/l

0.26

1042

3475

Other anxiety disorders

545

2183

2.19

60.93

2.3

1.7

1.78

1.70

mmol/l

0.91

536

2133

Presbycusis

277

939

3.01

60.68

2.0

1.9

1.64

1.68

mmol/l

0.36

271

917

Disorders of lipoprotein metabolism and other lipidaemias

952

3242

1.83

60.68

2.1

1.7

1.78

1.73

mmol/l

0.61

938

3153

Schizophrenia, schizotypal and delusional disorders

432

1839

2.39

60.65

2.6

1.8

1.73

1.72

mmol/l

0.05

424

1799

Diseases of oesophagus, stomach and duodenum

1285

4601

1.68

60.50

2.1

1.8

1.74

mmol/l

0.02

1264

4480

Paralytic ileus and intestinal obstruction

404

1673

2.46

60.38

2.3

1.8

1.71

1.74

mmol/l

0.26

399

1625

Schizophrenia or delusion

430

1833

2.38

60.19

2.6

1.8

1.73

1.72

mmol/l

0.04

422

1793

Osteoporosis

408

1590

2.45

59.42

2.4

1.8

1.57

1.70

mmol/l

2.33

400

1554

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1233

3964

1.70

59.35

2.2

1.7

1.70

1.76

mmol/l

0.98

1195

3875

Injuries to the thorax

630

3148

2.03

58.93

2.0

1.9

1.73

1.74

mmol/l

0.16

613

3076

Diseases of pulp and periapical tissues, including avohilmo

1272

3931

1.69

58.72

1.8

1.9

1.74

1.75

mmol/l

0.19

1241

3841

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1170

4429

1.71

58.66

2.0

1.8

1.69

1.75

mmol/l

1.09

1146

4318

Solid cancers, helper endpoint

971

3195

1.81

58.64

1.9

1.8

1.75

mmol/l

0.08

947

3124

Valvular operations

214

642

3.41

58.48

2.1

1.8

1.66

1.69

mmol/l

0.16

208

629

Hypotension

310

1152

2.76

58.31

2.4

1.9

1.65

1.72

mmol/l

0.66

304

1126

COPD-related respiratory insufficiency

225

701

3.31

58.13

3.2

1.9

1.62

1.77

mmol/l

1.96

218

683

Other cataract

564

2018

2.14

58.07

2.2

1.8

1.61

1.76

mmol/l

3.49

558

1965

Agranulocytosis

200

580

3.56

57.86

2.2

1.9

1.76

1.68

mmol/l

0.54

195

565

Other disorders of kidney and ureter

239

774

3.18

57.86

2.8

1.9

1.40

1.68

mmol/l

6.59

233

757

Other diseases of intestines

1247

4253

1.68

57.72

2.0

1.8

1.67

1.78

mmol/l

3.01

1224

4144

Coagulation defects, purpura and other haemorrhagic conditions

305

1129

2.76

57.68

2.5

1.9

1.85

1.68

mmol/l

1.76

294

1102

COPD, hospital admissions 1, only main diagnosis

523

2109

2.16

56.00

2.6

1.9

1.59

1.75

mmol/l

4.40

510

2063

Hypertensive heart and/or renal disease

346

1010

2.60

54.67

2.5

1.7

1.63

1.72

mmol/l

0.87

340

985

Diabetic nephropathy, excluding more controls

281

827

2.88

54.50

3.1

1.8

1.50

1.88

mmol/l

10.35

275

809

Other retinal disorders

834

3611

1.82

54.09

2.2

1.8

1.61

1.75

mmol/l

4.47

806

3532

Biguanides

1112

4041

1.69

53.51

2.1

1.7

1.94

1.66

mmol/l

13.32

1087

3943

External causes of morbidity and mortality

725

1877

1.95

52.90

2.0

1.7

1.67

1.76

mmol/l

1.37

708

1830

Endocarditis

126

6.93

52.66

2.7

1.6

1.63

1.67

mmol/l

0.13

121

Glomerulonephritis

188

560

3.47

52.28

3.2

1.9

1.45

1.68

mmol/l

3.75

183

549

Other and unspecified effects of external causes

365

1546

2.40

51.95

2.2

1.8

1.73

1.71

mmol/l

0.14

357

1513

Intestinal stricture

447

2080

2.18

50.89

2.3

1.9

1.74

1.72

mmol/l

0.19

441

2029

All anxiety disorders

682

2874

1.89

50.47

2.2

1.7

1.81

1.71

mmol/l

1.34

670

2810

Autoimmune diseases related-to ILD

987

5040

1.69

50.44

2.0

1.8

1.69

1.76

mmol/l

1.42

965

4917

Cerebrovascular diseases

934

3846

1.72

49.51

2.0

1.9

1.85

1.72

mmol/l

2.92

890

3772

Thrombocytopenia, unspecified

151

404

3.89

49.50

2.6

2.0

2.00

1.71

mmol/l

1.80

146

395

Non-allergic asthma (mode), excluding more controls

201

638

3.16

49.05

2.2

1.5

1.57

1.83

mmol/l

3.44

195

620

Dorsalgia

1150

3774

1.64

48.51

2.0

1.8

1.70

1.78

mmol/l

1.90

1135

3679

Cholelithiasis, broad definition with cholecystitis

1011

4094

1.67

48.08

1.9

1.8

1.75

1.72

mmol/l

0.39

985

3995

Focal epilepsy

311

1271

2.49

48.01

2.3

1.9

2.23

1.69

mmol/l

7.82

305

1245

Noninfective enteritis and colitis

580

3024

1.94

47.90

2.2

1.8

1.72

1.73

mmol/l

0.03

567

2958

Cholelithiasis

974

4019

1.68

47.48

1.9

1.8

1.75

1.72

mmol/l

0.46

947

3922

Lower back pain or/and sciatica

1227

5073

1.59

47.27

2.0

1.8

1.71

1.75

mmol/l

0.91

1203

4947

Non-invasive ventilation

195

553

3.18

47.02

3.4

1.3

1.68

1.65

mmol/l

0.14

188

542

Acute sinusitis

568

2742

1.93

46.39

2.1

1.7

1.61

1.77

mmol/l

4.34

554

2671

Gastrointestinal diseases

641

1666

1.94

46.34

2.1

1.6

1.65

1.81

mmol/l

3.83

626

1623

Abnormal results of function studies

153

436

3.62

45.57

2.2

1.9

1.64

1.68

mmol/l

0.28

147

426

Disorders of choroid and retina

973

4201

1.66

45.16

2.1

1.8

1.62

1.76

mmol/l

5.39

943

4109

Sequelae with surgical and medical care as external cause

304

1271

2.44

44.81

2.1

1.9

1.62

1.68

mmol/l

0.57

298

1243

Caries of dentine

309

1261

2.42

44.81

2.8

1.8

1.63

1.77

mmol/l

1.79

301

1236

Second line medication for Crohn's disease

670

3739

1.81

44.76

2.1

1.8

1.67

1.73

mmol/l

0.89

653

3652

Personality disorders

321

1373

2.37

44.73

2.6

1.8

1.82

1.72

mmol/l

0.64

316

1348

Fracture of rib(s), sternum and thoracic spine

423

2027

2.12

44.71

1.9

1.75

1.74

mmol/l

0.09

409

1978

Injuries to the abdomen, lower back, lumbar spine and pelvis

522

2668

1.96

44.50

2.3

1.9

1.72

mmol/l

0.04

499

2615

Other headache syndromes

446

2186

2.06

44.01

2.2

1.7

1.69

mmol/l

0.06

438

2132

Calcific aortic valvular stenosis, including rheumatic fever

443

2108

2.07

43.60

1.9

1.72

1.71

mmol/l

0.14

430

2055

Operations 2 for CAVS

441

2098

2.07

43.55

1.9

1.72

1.71

mmol/l

0.11

428

2045

Calcific aortic valvular stenosis, diagnosis (helper)

441

2098

2.07

43.55

1.9

1.72

1.71

mmol/l

0.11

428

2045

Calcific aortic valvular stenosis, operated

441

2099

2.07

43.50

1.9

1.72

1.71

mmol/l

0.12

428

2046

Calcific aortic valvular stenosis

441

2099

2.07

43.50

1.9

1.72

1.71

mmol/l

0.12

428

2046

Acute pancreatitis

282

1159

2.48

43.13

2.3

1.9

1.79

1.72

mmol/l

0.52

275

1130

Dental caries

337

1435

2.29

43.02

2.7

1.8

1.66

1.79

mmol/l

1.70

329

1406

Stroke, including SAH

804

3420

1.72

42.92

2.1

1.9

1.85

1.71

mmol/l

2.61

761

3350

Sub-endpoint used in defining T1D endpoints

390

1808

2.15

42.86

2.9

1.8

1.56

1.74

mmol/l

4.09

382

1772

Recurrent or chronic depression

406

1331

2.16

42.64

1.8

1.6

1.82

1.69

mmol/l

1.33

394

1298

Finngen Rheumatological endpoints

1070

3798

1.61

42.60

2.0

1.8

1.67

1.78

mmol/l

3.36

1054

3689

Other disorders of skin and subcutaneous tissue

821

4352

1.69

42.52

2.3

1.8

1.62

1.74

mmol/l

3.80

810

4244

Sequelae of external causes of morbidity and mortality

355

1621

2.23

42.51

2.1

1.9

1.65

1.72

mmol/l

0.70

347

1587

Asthma, including avohilmo

1355

5019

1.52

42.30

2.0

1.8

1.66

1.77

mmol/l

4.65

1323

4901

Glucagon-like peptide-1 (GLP-1) analogues

350

1594

2.23

42.11

2.2

1.8

1.96

1.68

mmol/l

5.87

343

1555

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

350

1594

2.23

42.11

2.2

1.8

1.96

1.68

mmol/l

5.87

343

1555

Dermatitis

725

4199

1.74

42.09

2.2

1.8

1.67

1.74

mmol/l

1.51

709

4096

Focal epilepsy, mode (most common among epilepsy diagnosis)

271

1110

2.49

41.75

2.3

1.9

2.31

1.70

mmol/l

8.08

265

1088

Disorders of adult personality and behaviour

328

1459

2.28

41.73

2.5

1.7

1.84

1.71

mmol/l

1.04

323

1427

severe traumatic brain injury, does not include concussion

334

1502

2.26

41.57

2.0

1.9

1.93

1.72

mmol/l

1.38

316

1472

Dizziness and giddiness

865

4157

1.66

41.31

2.0

1.8

1.70

1.74

mmol/l

0.66

845

4060

Peripheral artery disease

582

2515

1.86

41.16

2.5

1.8

1.70

1.74

mmol/l

0.48

569

2453

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

720

4150

1.73

41.07

2.2

1.8

1.60

1.74

mmol/l

5.48

707

4051

Focal epilepsy, strict definition

281

1182

2.42

40.83

2.3

1.9

2.29

1.70

mmol/l

7.95

275

1158

Non-selective monoamine reuptake inhibitors

439

2119

2.02

40.77

2.1

1.8

1.69

1.72

mmol/l

0.22

430

2065

Cutaneous abscess, furuncle and carbuncle

330

1490

2.25

40.58

2.4

1.8

1.74

1.72

mmol/l

0.14

323

1456

L04AX Other immunosuppressants

641

3638

1.78

40.51

2.2

1.8

1.67

1.73

mmol/l

0.73

625

3552

Transport accidents

477

2110

1.96

40.15

1.8

1.7

1.87

1.73

mmol/l

1.24

464

2058

Chronic nephritic syndrome

187

4.99

40.15

2.7

1.8

1.41

1.66

mmol/l

2.08

181

Disorders of thyroid, IBD co-morbidities

163

345

3.35

40.02

1.7

1.5

1.54

1.75

mmol/l

2.17

158

339

Chronic pancreatitis

195

696

2.87

39.80

2.4

1.9

1.76

mmol/l

0.02

190

679

Hypothyroidism, strict autoimmune

812

3191

1.69

39.60

2.0

1.8

1.71

1.76

mmol/l

0.78

792

3104

Other bacterial intestinal infections

257

1057

2.48

39.31

3.0

1.8

1.59

1.69

mmol/l

1.22

248

1033

Unspecified haematuria

542

2431

1.87

39.04

2.1

1.9

1.69

1.76

mmol/l

0.78

531

2373

Asthma/COPD (KELA code 203)

1042

4566

1.57

39.03

2.1

1.8

1.63

1.79

mmol/l

5.80

1015

4453

Supplementary factors related to causes of morbidity and mortality classified elsewhere

400

1978

2.05

38.86

2.2

1.8

1.79

1.70

mmol/l

0.95

389

1935

Purpura and other haemorrhagic conditions

207

772

2.74

38.84

2.5

1.9

1.88

1.70

mmol/l

1.38

200

755

Pain (limb, back, neck, head abdominally)

824

2449

1.70

38.79

2.0

1.8

1.71

1.81

mmol/l

2.01

810

2379

Specific personality disorders

274

1166

2.38

38.73

2.5

1.8

1.84

1.69

mmol/l

1.04

269

1143

Other noninfective gastroenteritis and colitis

329

1514

2.20

38.58

2.4

1.9

1.68

1.69

mmol/l

0.04

322

1482

Disorders of parathyroid gland

288

1240

2.33

38.56

2.3

1.7

1.49

1.67

mmol/l

3.75

281

1208

Other viral diseases

350

1646

2.15

38.51

2.4

1.9

1.57

1.74

mmol/l

3.45

344

1606

Non-allergic asthma (mode)

201

732

2.75

38.43

2.2

1.5

1.57

1.84

mmol/l

3.70

195

714

Viral infections characterized by skin and mucous membrane lesions

503

2711

1.87

37.75

2.2

1.8

1.61

1.74

mmol/l

2.42

495

2655

Hypertensive Heart Disease

284

952

2.37

37.69

2.5

1.7

1.63

1.73

mmol/l

0.89

279

927

Diseases of the skin and subcutaneous tissue

1134

3683

1.55

37.62

2.1

1.7

1.66

1.80

mmol/l

4.44

1115

3581

Atherosclerosis, excluding cerebral and coronary sclerosis

545

2364

1.85

37.48

2.5

1.8

1.69

1.74

mmol/l

0.58

532

2305

Other hearing loss

389

1888

2.04

37.40

2.1

1.9

1.67

1.70

mmol/l

0.22

382

1847

Factors influencing health status and contact with health services

344

769

2.26

36.91

2.0

1.5

1.71

1.86

mmol/l

1.48

337

752

Care involving use of rehabilitation procedures

653

3512

1.72

36.65

2.1

1.7

1.70

1.76

mmol/l

0.95

641

3417

Acute pancreatitis (for exclusion)

282

1248

2.30

36.56

2.3

1.9

1.79

1.72

mmol/l

0.53

275

1218

Migraine

457

1939

1.92

36.18

1.9

1.7

1.68

1.71

mmol/l

0.30

449

1894

Stroke, excluding SAH

752

3315

1.67

36.16

2.1

1.9

1.84

1.71

mmol/l

2.24

721

3243

Later onset COPD

403

1618

2.02

35.79

2.5

1.8

1.68

1.74

mmol/l

0.53

395

1579

Abnormal findings on diagnostic imaging of lung

593

3270

1.76

35.71

2.3

1.8

1.60

1.75

mmol/l

3.82

582

3188

Bacterial pneumoniae

424

1929

1.96

35.61

2.6

1.6

1.70

1.81

mmol/l

1.18

419

1881

Unstable angina pectoris

442

1820

1.94

35.26

2.2

1.8

1.65

1.76

mmol/l

1.74

436

1770

Bipolar affective disorders

212

841

2.56

34.98

2.3

1.8

1.76

1.71

mmol/l

0.35

205

823

Aortic aneurysm

324

1513

2.13

34.90

1.9

1.8

1.63

1.79

mmol/l

2.49

318

1476

Hernia of abdominal wall

551

3140

1.77

34.57

2.1

1.9

1.73

1.74

mmol/l

0.08

539

3071

Other diseases of liver

241

1022

2.40

34.52

2.5

1.9

1.77

1.69

mmol/l

0.69

236

996

Diabetic retinopathy, excluding more controls

375

1017

2.10

34.33

2.5

1.8

1.59

1.89

mmol/l

7.27

367

998

Cardiac arrest

156

4.70

34.32

2.5

1.5

1.85

1.84

mmol/l

0.03

150

Type of accident

362

1813

2.02

34.04

2.2

1.8

1.80

1.70

mmol/l

1.03

351

1776

Other bacterial intestinal infections

290

1339

2.20

33.87

2.9

1.7

1.60

1.70

mmol/l

1.36

281

1310

Certain disorders involving the immune mechanism

252

1102

2.33

33.65

2.4

1.9

1.56

1.71

mmol/l

1.92

245

1074

Diabetic nephropathy

284

1291

2.23

33.64

3.1

2.0

1.53

1.87

mmol/l

10.63

278

1262

Injury, poisoning and certain other consequences of external causes

552

1523

1.83

33.61

2.1

1.7

1.65

1.76

mmol/l

1.82

541

1489

Asthma, hospital admissions , main diagnosis only

908

5187

1.55

33.60

2.1

1.8

1.62

1.76

mmol/l

5.67

884

5067

Other arthritis (FG)

364

1838

2.00

33.41

2.2

1.8

1.70

1.75

mmol/l

0.38

354

1785

Enterocolitis due to Clostridium difficile

173

640

2.77

33.09

3.2

1.8

1.53

1.73

mmol/l

3.05

166

625

Other and unspecified dermatitis

584

3426

1.72

33.00

2.2

1.8

1.66

1.73

mmol/l

1.06

571

3345

Phlebitis and thrombophlebitis (not including DVT)

285

1322

2.19

32.94

2.1

1.9

1.65

1.71

mmol/l

0.51

278

1290

Bacterial intestinal infections, IBD co-morbidities

255

1132

2.29

32.88

3.0

1.8

1.59

1.69

mmol/l

1.24

246

1106

Injuries to the shoulder and upper arm

948

5025

1.53

32.23

1.8

1.9

1.78

1.74

mmol/l

0.39

928

4907

Other/unspecified dorsalgia

428

2289

1.87

32.15

2.3

1.8

1.64

1.74

mmol/l

1.25

421

2230

Soft tissue disorders

1129

3899

1.50

32.13

1.9

1.8

1.67

1.79

mmol/l

4.05

1100

3804

Hypothyreosis and Thyroxine purchase for inclusion criteria

1001

4343

1.52

32.03

2.1

1.8

1.69

1.73

mmol/l

0.74

975

4239

Other neurological diseases

830

4179

1.57

31.74

2.1

1.9

1.73

mmol/l

0.00

808

4078

Other viral diseases

404

2133

1.90

31.69

2.2

1.9

1.58

1.75

mmol/l

3.72

397

2084

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

651

3975

1.65

31.44

2.2

1.8

1.61

1.73

mmol/l

3.45

638

3885

Dorsopathies

1117

3815

1.50

31.43

1.9

1.8

1.68

1.78

mmol/l

2.73

1092

3720

Dental pulpitis, including avohilmo

947

4037

1.53

31.24

2.0

1.8

1.69

1.76

mmol/l

1.50

918

3950

Other dorsopathies, not elsewhere classified

1082

3791

1.50

31.20

2.0

1.8

1.70

1.78

mmol/l

1.72

1065

3696

Neoplasms

787

2602

1.61

31.07

2.0

1.8

1.70

1.77

mmol/l

1.28

772

2539

Gastro-oesophageal reflux disease

752

4107

1.59

30.75

2.1

1.8

1.73

1.74

mmol/l

0.07

741

4001

Injuries to the hip and thigh

577

3108

1.70

30.59

2.1

1.9

1.75

1.72

mmol/l

0.25

566

3036

Malignant neoplasm of digestive organs

444

1922

1.84

30.51

1.9

1.82

1.74

mmol/l

0.83

438

1879

Injuries to the ankle and foot

736

4137

1.59

30.34

2.0

1.8

1.70

1.75

mmol/l

0.82

723

4042

Hypothyroidism, other/unspecified

961

4205

1.51

29.97

2.1

1.8

1.70

1.74

mmol/l

0.65

937

4100

Other specified/unspecified arthritis

318

1594

2.02

29.89

2.3

1.8

1.74

1.77

mmol/l

0.15

309

1552

Hypertrophy of (infrapatellar) fat pad

10.55

29.85

2.0

1.9

1.58

1.66

mmol/l

0.22

294

1344

2.09

29.82

2.0

1.9

1.65

1.70

mmol/l

0.47

283

1311

Dysphagia

294

1438

2.07

29.60

2.5

1.8

1.55

1.74

mmol/l

3.37

288

1400

Ischaemic Stroke, excluding all haemorrhages

688

3196

1.62

29.25

2.1

1.9

1.81

1.72

mmol/l

1.22

667

3119

Other degenerative diseases of the nervous system

302

1097

2.08

29.12

1.9

1.7

1.76

1.70

mmol/l

0.48

297

1079

Adverse effects, not elsewhere classified

233

1049

2.25

29.06

2.3

1.8

1.68

1.67

mmol/l

0.04

225

1022

Meniscus derangement

622

2551

1.65

28.64

1.8

1.71

1.80

mmol/l

1.38

612

2480

Disorders of the thyroid gland

1016

4504

1.48

28.29

2.0

1.8

1.70

1.75

mmol/l

0.97

994

4395

Internal derangement of knee

412

2278

1.82

28.22

2.1

1.8

1.65

1.79

mmol/l

2.33

406

2219

Alcoholic liver disease

155

591

2.69

28.05

2.9

2.0

2.04

1.71

mmol/l

2.75

155

578

Primary_lymphoid and hematopoietic malignant neoplasms

314

1606

1.98

27.99

2.2

1.9

1.68

1.70

mmol/l

0.17

305

1573

Organic, including symptomatic, mental disorders

626

2744

1.64

27.94

2.2

1.9

1.82

1.71

mmol/l

1.48

614

2684

Exclusions for E4_PCOS_CONSORTIUM

707

2806

1.59

27.25

2.0

1.8

1.66

1.69

mmol/l

0.38

696

2736

Hypothyroidism, strict autoimmune, 3 medication purchases required

882

3981

1.50

27.12

2.0

1.8

1.68

1.72

mmol/l

0.63

859

3887

Diseases of the eye and adnexa

817

2656

1.55

27.03

2.0

1.8

1.68

1.82

mmol/l

3.81

807

2581

Necrosis of pulp, including avohilmo

591

3660

1.62

26.87

1.8

1.67

1.75

mmol/l

1.20

582

3573

Fluid overload

36.70

26.84

4.8

1.7

1.31

1.58

mmol/l

0.72

Diseases of the musculoskeletal system and connective tissue

566

1692

1.69

26.43

2.0

1.8

1.68

1.87

mmol/l

4.02

558

1642

Nonorganic sleeping disorders, excluding more controls

192

829

2.34

26.43

2.4

1.7

1.80

1.68

mmol/l

0.94

187

811

Fracture of foot, except ankle

274

1368

2.03

26.13

2.2

1.8

1.66

1.72

mmol/l

0.54

268

1337

Leisure time condition

230

1079

2.16

25.99

2.3

1.9

1.81

1.70

mmol/l

0.87

223

1056

Viral infections characterized by skin and mucous membrane lesions

916

5365

1.47

25.88

2.0

1.9

1.65

1.76

mmol/l

2.59

899

5237

Other symptoms and signs involving cognitive functions and awareness

531

2945

1.66

25.82

2.3

1.8

1.77

1.73

mmol/l

0.40

514

2881

Injuries to the knee and lower leg

1267

5049

1.40

25.66

2.1

1.8

1.69

1.76

mmol/l

1.45

1242

4924

Superficial injury of head

270

1359

2.01

25.17

2.1

1.8

1.74

1.71

mmol/l

0.10

264

1327

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

568

2787

1.62

25.15

1.9

1.8

1.74

1.69

mmol/l

0.47

553

2723

Hyperparathyroidism

231

1091

2.12

24.88

2.3

1.7

1.43

1.67

mmol/l

6.31

225

1063

Arthropathies in other diseases classified elsewhere

165

4.21

24.82

2.9

1.8

1.57

1.68

mmol/l

0.51

157

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

273

1373

1.98

24.59

2.3

1.8

1.67

1.69

mmol/l

0.14

267

1343

Injuries to the neck

260

1304

2.02

24.54

1.9

1.76

1.73

mmol/l

0.19

252

1276

373

1824

1.80

24.34

1.9

1.66

1.71

mmol/l

0.56

358

1781

Noninfectious colitis NAS

174

756

2.34

23.77

2.4

1.9

1.65

1.70

mmol/l

0.29

169

738

Other embolism and thrombosis

167

713

2.38

23.76

2.2

1.9

1.68

mmol/l

0.01

162

696

Eosinophilic disease (BM)

8.19

23.61

2.6

1.3

1.71

1.73

mmol/l

0.06

Peripheral arterial reconstruction

236

1163

2.06

23.52

2.7

1.9

1.65

1.71

mmol/l

0.57

231

1132

Other diseases of biliary tract

130

497

2.67

23.48

2.2

1.9

1.63

1.66

mmol/l

0.15

125

486

Other diseases of pancreas

124

465

2.73

23.30

2.3

2.0

1.69

1.66

mmol/l

0.17

124

454

Nerve, nerve root and plexus disorders

1114

4904

1.40

22.95

2.0

1.8

1.67

1.76

mmol/l

1.98

1091

4784

Sensorineural hearing loss

828

3845

1.47

22.86

2.0

1.9

1.71

1.75

mmol/l

0.64

812

3757

Bacterial pneumonia (organism specified)

503

2829

1.62

22.81

2.6

1.8

1.69

1.74

mmol/l

0.45

495

2761

Fracture of shoulder and upper arm

407

2400

1.71

22.72

1.9

1.80

1.72

mmol/l

0.66

397

2345

Other infectious diseases

117

432

2.77

22.65

2.9

2.0

1.52

1.71

mmol/l

1.80

117

423

Gastroduodenal ulcer

329

1828

1.81

22.56

2.4

1.9

1.77

1.72

mmol/l

0.35

323

1781

Ventral hernia

294

1585

1.88

22.46

2.1

1.8

1.76

1.71

mmol/l

0.28

287

1555

Vitreous haemorrhage

141

574

2.51

22.37

2.4

2.0

1.42

1.67

mmol/l

3.90

135

563

Dermatitis and eczema

1163

5246

1.38

22.30

2.1

1.8

1.66

1.76

mmol/l

3.10

1140

5117

Other disorders of ear

961

4451

1.42

22.01

2.1

1.9

1.72

1.75

mmol/l

0.28

939

4346

Candidiasis

305

1673

1.84

22.01

2.4

1.8

1.65

1.69

mmol/l

0.26

295

1641

Striking against or struck by other objects

351

2018

1.75

21.52

1.8

1.9

1.70

1.74

mmol/l

0.35

342

1972

Reimbursement for rheumatic diseases

583

3789

1.54

21.51

2.0

1.8

1.69

1.73

mmol/l

0.39

570

3701

Congenital malformations, deformations and chromosomal abnormalities

569

3515

1.55

21.40

2.0

1.8

1.69

1.73

mmol/l

0.38

554

3440

Superficial injury of abdomen, lower back and pelvis

181

836

2.19

21.37

2.3

1.9

1.76

1.69

mmol/l

0.34

175

819

Diabetic maculopathy

201

911

2.12

21.31

2.8

2.0

1.53

1.86

mmol/l

5.54

195

888

DVT of lower extremities

226

1138

2.01

21.21

2.2

1.9

1.79

1.71

mmol/l

0.65

219

1115

Conductive and sensorineural hearing loss

847

3984

1.44

21.20

2.0

1.9

1.71

1.75

mmol/l

0.62

830

3893

Missing teeth due to accident, extraction or parodontitis

642

4043

1.51

21.03

2.1

1.9

1.65

1.74

mmol/l

1.61

630

3946

Glaucoma

619

3537

1.52

20.67

1.9

1.76

1.72

mmol/l

0.42

608

3453

Other and unspecified tonsillitis

300

1390

1.83

20.67

1.9

1.8

1.73

1.83

mmol/l

0.90

295

1355

Diseases of the ear and mastoid process

1195

4417

1.36

20.50

2.0

1.8

1.71

1.76

mmol/l

1.11

1174

4310

Superficial injury of lower leg

267

1439

1.87

20.43

2.3

1.8

1.60

1.70

mmol/l

1.08

261

1409

Abnormal findings on examination of blood, without diagnosis

539

3216

1.55

20.14

2.5

1.9

1.79

1.74

mmol/l

0.52

522

3142

Arthropathies

916

3280

1.42

20.10

2.0

1.8

1.68

1.80

mmol/l

3.46

903

3191

Primary open-angle glaucoma, strict

318

1815

1.77

20.03

1.9

1.84

1.69

mmol/l

1.41

313

1771

Diseases of pulp and periapical tissues and dental caries

724

2515

1.48

19.84

1.9

1.72

1.77

mmol/l

0.59

706

2458

Cholecystectomy

725

4332

1.45

19.57

1.8

1.9

1.78

1.71

mmol/l

1.06

706

4230

Sulfasalazine

270

1483

1.84

19.44

2.0

1.7

1.73

1.74

mmol/l

0.05

264

1447

Abnormal findings on diagnostic imaging of other body structures

164

758

2.20

19.42

2.1

1.9

1.73

1.70

mmol/l

0.11

159

739

Inflammatory bowel disease

327

1902

1.73

19.38

2.0

1.8

1.76

1.71

mmol/l

0.32

321

1858

Caries of dentine, including avohilmo

851

3055

1.43

19.37

1.9

1.73

1.76

mmol/l

0.39

828

2982

Rheumatoid arthritis

334

1745

1.73

19.34

2.1

1.8

1.62

1.75

mmol/l

2.28

327

1697

Presence of cardiac and vascular implants and grafts

457

2129

1.61

19.32

2.0

1.8

1.71

1.78

mmol/l

0.85

448

2063

Degeneration of macula and posterior pole

534

2778

1.54

19.04

1.9

1.63

1.73

mmol/l

2.16

515

2719

Fracture of femur

324

1707

1.74

19.04

2.1

1.9

1.81

1.70

mmol/l

0.82

318

1668

Mouth breathing

416

2587

1.62

18.98

2.0

1.9

1.73

1.75

mmol/l

0.13

410

2525

Polyarthrosis

226

1094

1.94

18.97

1.9

1.8

1.68

1.74

mmol/l

0.46

221

1062

Periapical abscess

455

2894

1.58

18.96

2.0

1.9

1.67

1.75

mmol/l

1.00

442

2832

Fracture of lumbar spine and pelvis

268

1480

1.83

18.95

2.2

1.9

1.71

1.68

mmol/l

0.16

257

1451

Malignant neoplasm of respiratory system and intrathoracic organs

239

1051

1.91

18.91

2.0

1.9

1.73

1.74

mmol/l

0.09

234

1028

Congenital malformations, deformations and chromosomal abnormalities

615

3835

1.48

18.90

2.0

1.8

1.70

1.74

mmol/l

0.29

600

3750

Fracture of lower leg, including ankle

558

3678

1.51

18.79

2.1

1.8

1.74

1.75

mmol/l

0.09

548

3586

Bacterial pneumonia, not elsewhere classified

350

1832

1.69

18.75

2.5

1.6

1.70

1.80

mmol/l

0.99

345

1785

Dental caries, including avohilmo

807

2891

1.43

18.74

1.9

1.70

1.77

mmol/l

1.04

784

2821

Diabetic retinopathy

465

1829

1.60

18.68

2.6

2.1

1.62

1.88

mmol/l

7.86

455

1785

Systemic connective tissue disorders

372

2266

1.66

18.57

2.3

1.8

1.68

mmol/l

0.03

366

2211

Artificial joint operation, meniscal resection

948

4476

1.38

18.55

1.8

1.9

1.69

1.75

mmol/l

1.30

936

4358

Varicose veins

628

3229

1.48

18.23

1.9

1.70

1.72

mmol/l

0.28

613

3154

Diverticular disease of intestine

720

3196

1.45

18.20

2.0

1.8

1.67

1.76

mmol/l

1.87

705

3106

Folate deficiency anaemia

7.17

18.13

4.1

2.0

2.07

1.54

mmol/l

1.97

Ulcerative colitis

256

1417

1.82

18.05

2.0

1.8

1.78

1.71

mmol/l

0.42

251

1384

Zoster [herpes zoster]

215

1130

1.93

17.91

2.2

1.9

1.57

1.67

mmol/l

1.10

209

1108

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

340

2056

1.67

17.50

2.0

1.8

1.66

1.70

mmol/l

0.38

331

2011

Somnolence, stupor and coma

221

3.21

17.36

3.2

1.9

1.95

1.65

mmol/l

1.10

216

Spinal stenosis

538

2728

1.51

17.27

2.0

1.9

1.70

1.77

mmol/l

0.91

529

2655

Other symptoms and signs involving the urinary system

132

587

2.29

17.26

1.9

1.71

1.74

mmol/l

0.11

126

576

Polycystic ovarian syndrome, consortium definition

617

2487

1.48

17.21

1.8

1.68

mmol/l

0.06

602

2430

Other disorders of lacrimal gland

354

2175

1.64

17.12

2.2

1.8

1.54

1.70

mmol/l

3.20

349

2123

Primary open-angle glaucoma

364

2190

1.62

16.67

1.9

1.80

1.69

mmol/l

1.06

359

2138

Peripheral artery operations in Hilmo

161

785

2.08

16.65

3.5

1.9

1.58

1.76

mmol/l

2.08

161

766

Examination and observation for other reasons

309

2936

0.61

16.39

2.1

1.7

1.71

1.78

mmol/l

0.50

299

2871

Urticaria and erythema

349

2160

1.63

16.38

2.2

1.8

1.64

1.70

mmol/l

0.71

343

2113

Open wound of lower leg

174

878

2.01

16.38

2.6

1.8

1.54

1.70

mmol/l

1.66

169

861

Statin medication

635

2464

1.46

16.34

2.0

1.8

1.76

1.75

mmol/l

0.11

621

2402

Zoster [herpes zoster]

505

3342

1.50

16.33

2.0

1.8

1.64

1.73

mmol/l

1.69

492

3267

Mycoses

282

1658

1.72

16.21

2.8

1.8

1.60

1.69

mmol/l

1.21

274

1624

Benign paroxysmal vertigo

316

1917

1.66

16.14

1.9

1.8

1.58

1.67

mmol/l

1.40

309

1874

Gonarthrosis [arthrosis of knee](FG)

739

3060

1.41

16.14

1.8

1.69

1.78

mmol/l

2.06

726

2968

Malignant neoplasm of breast, HER2-negative

348

1389

1.65

16.11

1.8

1.75

1.67

mmol/l

0.82

338

1360

Other joint disorders

852

3272

1.38

15.98

1.9

1.8

1.67

1.81

mmol/l

3.82

837

3183

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

474

2122

1.52

15.83

2.0

1.9

1.61

1.73

mmol/l

2.31

464

2074

Candidiasis

148

715

2.10

15.72

2.8

1.8

1.56

1.65

mmol/l

0.68

143

696

Other systemic involvement of connective tissue (FG)

257

1465

1.75

15.71

2.3

1.8

1.67

1.72

mmol/l

0.30

252

1419

Malignant neoplasm of breast, HER2-negative, including Hilmo

354

1413

1.63

15.70

1.8

1.73

1.67

mmol/l

0.64

344

1384

Malignant neoplasm of breast, including Hilmo

354

1413

1.63

15.70

1.8

1.73

1.67

mmol/l

0.64

344

1384

Hernia

936

4684

1.34

15.66

2.0

1.9

1.70

1.75

mmol/l

0.82

914

4573

Malignant neoplasm of breast

349

1400

1.64

15.66

1.8

1.74

1.67

mmol/l

0.71

339

1371

Disorders of lacrimal system

423

2781

1.53

15.14

2.2

1.8

1.58

1.72

mmol/l

2.58

418

2712

Injuries to the elbow and forearm

687

4362

1.39

14.84

2.0

1.9

1.77

1.73

mmol/l

0.38

667

4260

Mixed disorders of conduct and emotions, excluding more controls

5.61

14.83

2.4

1.6

1.63

1.59

mmol/l

0.15

Intestinal adhesions without obstruction

108

472

2.33

14.80

2.0

1.8

1.60

1.70

mmol/l

0.81

108

456

Dental operations

662

2408

1.42

14.64

2.0

1.8

1.70

1.79

mmol/l

1.42

647

2351

Congenital malformations of cardiac septa

313

2.61

14.50

2.3

2.1

1.78

1.71

mmol/l

0.21

307

Pneumothorax

348

2.55

14.50

2.3

1.8

1.67

1.73

mmol/l

0.29

339

Visual disturbances

481

3296

1.47

14.26

2.1

1.8

1.68

1.72

mmol/l

0.38

471

3220

Pure hypercholesterolaemia

659

3083

1.40

14.24

2.1

1.7

1.80

1.74

mmol/l

0.77

652

2999

Disorders of ocular muscles, binocular movement, accommodation and refraction

440

2942

1.49

14.10

2.2

1.8

1.67

1.73

mmol/l

0.61

433

2882

Other malignant neoplasms of skin (=non-melanoma skin cancer)

440

2018

1.50

13.90

2.0

1.9

1.62

1.73

mmol/l

1.84

430

1973

Arthrosis

687

2720

1.39

13.85

1.9

1.8

1.73

1.80

mmol/l

1.11

672

2645

Other disorders of veins

372

2422

1.54

13.77

2.1

1.8

1.63

1.71

mmol/l

0.96

363

2368

Gonarthrosis

627

2551

1.41

13.53

1.8

1.68

1.80

mmol/l

2.82

618

2478

5-aminosalicylic acid

190

1052

1.82

13.52

1.9

1.7

1.76

1.77

mmol/l

0.06

185

1025

Exposure to other specified factors

720

4897

1.35

13.38

2.1

1.8

1.66

1.76

mmol/l

2.15

707

4783

Other or ill-defined heart diseases

197

2.99

13.22

2.0

1.6

1.70

mmol/l

0.02

192

Malignant neoplasm of skin

468

2197

1.47

13.17

1.9

1.61

1.74

mmol/l

2.28

453

2148

Urticaria

270

1661

1.64

13.12

2.1

1.9

1.64

1.68

mmol/l

0.27

264

1625

Visual disturbances and blindness

509

3582

1.43

13.09

2.1

1.8

1.68

1.72

mmol/l

0.45

497

3500

Disorders of vestibular function (Vertigo)

464

3159

1.45

13.07

2.0

1.8

1.66

1.72

mmol/l

0.86

454

3086

Behavioural syndromes associated with physiological disturbances and physical factors

875

4742

1.31

12.68

2.0

1.8

1.77

1.74

mmol/l

0.34

852

4630

Coxarthrosis [arthrosis of hip](FG)

532

2648

1.42

12.67

1.8

1.71

1.78

mmol/l

0.82

524

2570

Amputation of toe

448

2.25

12.60

3.9

1.8

1.62

1.71

mmol/l

0.48

435

Other fall from one level to another

227

1352

1.69

12.55

2.0

1.77

1.73

mmol/l

0.19

219

1328

Sequelae of injuries, of poisoning and of other consequences of external causes

230

1376

1.69

12.52

2.0

1.9

1.81

1.73

mmol/l

0.36

219

1345

Combinations of oral blood glucose lowering drugs

280

1761

1.60

12.50

2.1

1.8

1.95

1.67

mmol/l

5.18

271

1722

Irritable bowel syndrome

245

1492

1.65

12.43

2.0

1.7

1.60

1.70

mmol/l

1.10

239

1454

Coxarthrosis

492

2276

1.43

12.25

1.8

1.9

1.71

1.79

mmol/l

1.03

485

2214

Septal defects

298

2.51

12.14

2.3

2.2

1.81

1.72

mmol/l

0.27

292

Other necrotizing vasculopathies (FG)

308

2.48

11.92

2.4

1.8

1.68

1.64

mmol/l

0.14

297

Assault by bodily force

344

2.39

11.91

1.8

1.9

1.68

1.74

mmol/l

0.31

338

Nonorganic sleeping disorders

192

1110

1.74

11.88

2.4

1.9

1.80

1.69

mmol/l

0.77

187

1090

Fall on and from stairs and steps

262

1643

1.61

11.87

2.2

1.9

1.81

1.68

mmol/l

1.28

252

1610

Tracheo-bronchomalasia

32.39

11.84

1.5

1.2

1.99

1.26

mmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

124

628

2.00

11.72

2.4

1.9

1.84

1.73

mmol/l

0.58

118

615

Disorders of sclera, cornea, iris and ciliary body

519

3742

1.39

11.70

2.0

1.8

1.64

1.74

mmol/l

1.35

508

3658

Disorders of eyelid, lacrimal system and orbit

828

4835

1.30

11.65

2.0

1.9

1.64

1.75

mmol/l

2.75

813

4714

Caries of enamel

476

4795

0.71

11.62

1.9

1.79

1.74

mmol/l

0.47

471

4673

Spondyloarthritis

176

1000

1.77

11.58

2.2

1.8

1.58

1.71

mmol/l

1.41

169

978

Diseases of oral cavity, salivary glands and jaws

634

2394

1.37

11.48

2.0

1.8

1.71

1.77

mmol/l

0.95

623

2339

IBD patients in KELA-register

210

1261

1.68

11.32

1.8

1.80

1.72

mmol/l

0.49

205

1235

Deforming dorsopathies

256

1617

1.59

11.26

1.8

1.67

1.72

mmol/l

0.34

251

1576

Personal history of risk-factors, not elsewhere classified

5.42

11.15

4.9

1.9

1.74

1.66

mmol/l

0.19

Brachial plexus disorders

393

2.24

11.10

1.5

1.9

1.70

1.69

mmol/l

0.03

387

Fall on same level involving ice and snow

542

3976

1.37

11.02

1.9

1.66

1.74

mmol/l

1.44

535

3884

Sulfonylureas

365

1978

1.48

11.00

2.4

1.8

1.80

1.64

mmol/l

2.93

354

1930

Myocardial infarction, unclassifiable

254

1436

1.59

10.90

2.3

1.9

1.71

1.74

mmol/l

0.17

249

1399

Non-small cell lung cancer, adenocarcinoma

310

2.40

10.82

1.7

1.9

1.57

1.72

mmol/l

0.85

302

Nontraumatic intracranial haemmorrhage

219

1350

1.64

10.70

2.1

1.9

1.96

1.68

mmol/l

2.81

191

1321

Basal cell carcinoma, including avohilmo

418

2014

1.44

10.68

1.9

1.60

1.73

mmol/l

2.57

407

1969

Unspecified misadventure during surgical and medical care

288

2.44

10.64

2.1

1.9

1.56

1.71

mmol/l

0.87

281

Irregular menses

351

1889

1.47

10.48

1.8

1.69

1.68

mmol/l

0.06

344

1845

Malignant neoplasm of breast, HER-positive

257

1278

1.58

10.46

1.8

1.72

1.67

mmol/l

0.44

252

1252

Sleep disorders

818

4603

1.29

10.44

1.9

1.8

1.78

1.74

mmol/l

0.46

794

4495

Other and unspecified immunodeficiencies with predominantly antibody defects

4.89

10.35

3.2

1.9

1.61

1.59

mmol/l

0.04

Sciatica+with lumbago

452

2989

1.40

10.32

2.0

1.8

1.68

1.76

mmol/l

1.01

445

2914

In situ neoplasms

368

2558

1.45

10.31

2.0

1.8

1.64

1.70

mmol/l

0.59

357

2501

Eustachian salpingitis and obstruction

329

2.31

10.30

1.7

1.87

1.70

mmol/l

0.52

324

Polyneuropathies and other disorders of the peripheral nervous system

232

1467

1.60

10.25

2.7

1.9

1.63

1.71

mmol/l

0.79

227

1434

Rheumatoid arthritis, including avohilmo

359

2492

1.45

10.14

2.0

1.8

1.62

1.71

mmol/l

1.37

350

2436

Mixed disorders of conduct and emotions

4.03

10.08

2.4

1.9

1.63

1.87

mmol/l

0.63

Viral warts

490

2.04

10.05

2.1

1.9

1.64

1.67

mmol/l

0.12

480

Malignant neoplasm of breast, ER-positive, including Hilmo

258

1283

1.56

10.02

1.8

1.73

1.67

mmol/l

0.45

253

1256

Glaucoma suspect

354

2458

1.45

10.00

1.9

1.73

1.70

mmol/l

0.21

348

2401

Obesity, other/unspecified

278

1842

1.52

9.92

2.2

1.7

1.79

1.67

mmol/l

1.37

270

1805

Alcohol-induced acute pancreatitis

185

2.77

9.91

2.5

2.2

1.77

1.62

mmol/l

0.53

178

Inflammatory diseases of female pelvic organs

481

2583

1.37

9.67

1.9

1.7

1.66

1.68

mmol/l

0.22

469

2522

Maternal care for other conditions predominantly related to pregnancy

140

772

1.79

9.58

1.6

1.70

1.73

mmol/l

0.14

135

760

Other necrotizing vasculopathies

421

2.10

9.45

2.4

1.9

1.71

1.68

mmol/l

0.15

410

Insomnia

786

4498

1.28

9.44

1.9

1.8

1.79

1.74

mmol/l

0.60

763

4396

Basal cell carcinoma

399

1963

1.41

9.38

1.9

1.8

1.60

1.74

mmol/l

2.46

387

1919

Follow-up examination after treatment for conditions other than malignant neoplasms

241

2423

0.66

9.38

1.8

1.7

1.63

1.77

mmol/l

2.08

233

2371

Inflammatory bowel disease, strict (require KELA)

210

1325

1.60

9.38

1.8

1.80

1.73

mmol/l

0.45

205

1298

Generalized anxiety disorder

120

652

1.85

9.25

2.4

1.7

1.82

1.67

mmol/l

0.76

115

639

Other systemic involvement of connective tissue

258

1713

1.52

9.19

2.3

1.8

1.67

mmol/l

0.03

252

1672

Oesophageal varices

218

2.53

9.02

3.2

2.1

1.90

1.70

mmol/l

0.67

212

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

195

760

1.64

9.02

1.5

1.7

1.53

1.79

mmol/l

4.24

190

743

Other and unspecified polyneuropathies, also in other diseases

202

1279

1.59

8.96

2.8

1.9

1.61

1.72

mmol/l

1.19

197

1250

Transient ischemic attack

517

3142

1.34

8.90

2.0

1.9

1.72

mmol/l

0.01

505

3067

Inflammatory disease of uterus

109

583

1.88

8.86

1.8

1.6

1.72

1.65

mmol/l

0.43

109

569

Car occupant injured in other and unspecified transport accidents

170

1034

1.66

8.85

1.9

1.8

1.86

1.71

mmol/l

1.02

163

1015

Other obstetric conditions, not elsewhere classified

200

790

1.62

8.84

1.5

1.7

1.53

1.78

mmol/l

3.96

195

773

Symptoms and signs involving speech and voice

307

2131

1.45

8.76

2.0

1.8

1.68

1.72

mmol/l

0.30

300

2087

Intracerebral haemorrhage

140

812

1.74

8.74

2.2

2.0

1.95

1.70

mmol/l

1.50

125

795

Pneumonia derived septicemia

170

2.70

8.60

3.0

1.7

1.58

1.67

mmol/l

0.32

164

Outcome of delivery

436

0.27

8.60

1.5

1.9

1.86

1.75

mmol/l

0.16

430

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

263

1780

1.49

8.56

1.9

1.74

1.73

mmol/l

0.05

258

1743

Pediculosis, acariasis and other infestations

286

2.27

8.51

2.2

2.0

1.66

1.67

mmol/l

0.06

280

Testicular dysfunction

171

2.68

8.51

1.8

1.9

1.63

1.67

mmol/l

0.13

166

Astigmatism

292

2.25

8.50

2.7

2.1

1.74

1.69

mmol/l

0.17

286

Pain in joint

482

2287

1.35

8.48

2.0

1.8

1.61

1.80

mmol/l

5.68

469

2221

Ovarian cyst

294

1155

1.47

8.46

1.8

1.60

1.70

mmol/l

1.22

288

1133

Urolithiasis

321

2266

1.43

8.38

1.7

1.9

1.71

1.74

mmol/l

0.18

312

2216

Hyperplasia of prostate

370

1499

1.41

8.30

1.9

2.0

1.66

1.87

mmol/l

3.15

357

1462

Diseases of inner ear

507

3723

1.32

8.29

2.0

1.8

1.64

1.72

mmol/l

1.74

496

3637

Lesion of ulnar nerve

132

766

1.74

8.25

2.2

1.9

1.72

1.73

mmol/l

0.05

127

749

Calculus of kidney and ureter

293

2054

1.44

7.98

1.7

1.9

1.73

1.74

mmol/l

0.06

284

2007

Toxic effect of corrosive substances

10.04

7.93

4.5

2.9

2.03

1.68

mmol/l

0.44

Any dementia, excluding more controls

360

1788

1.39

7.86

2.0

1.8

1.83

1.68

mmol/l

1.52

354

1748

Excessive earwax

525

3943

1.30

7.82

1.8

1.9

1.71

1.74

mmol/l

0.27

516

3851

Osteomyelitis of vertebra

13.11

7.79

3.9

1.5

1.72

1.65

mmol/l

0.08

Inflammatory diseases of prostate (prostatitis)

134

795

1.70

7.77

2.2

1.9

1.69

1.84

mmol/l

1.08

134

776

Orchitis and epididymitis

101

552

1.85

7.76

2.1

2.0

1.74

1.85

mmol/l

0.40

101

541

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

484

3583

1.32

7.76

1.9

1.74

1.76

mmol/l

0.19

477

3503

Other female pelvic inflammatory diseases

135

803

1.69

7.73

1.8

1.7

1.57

1.66

mmol/l

0.70

128

788

Suppurative and unspecified otitis media

296

1847

1.43

7.72

2.3

1.8

1.84

1.71

mmol/l

0.75

290

1806

Diseases of male genital organs

513

1964

1.32

7.65

2.0

1.9

1.71

1.89

mmol/l

2.92

504

1917

Thyrotoxicosis, other and/or unspecified

171

1085

1.59

7.57

1.8

1.61

1.64

mmol/l

0.16

166

1058

malignant neoplasm of male genital organs

281

1188

1.45

7.51

1.7

2.0

1.87

1.80

mmol/l

0.39

275

1158

Secondary parkinsonism, excluding more controls

3.31

7.42

2.2

1.8

1.55

1.59

mmol/l

0.08

Wet age-related macular degeneration

185

1165

1.55

7.41

1.9

1.64

1.67

mmol/l

0.20

178

1136

Sequelae of cerebrovascular disease

358

2263

1.37

7.40

2.2

1.9

1.85

1.69

mmol/l

1.69

350

2214

Other specific joint derangements/joint disorders

619

3147

1.27

7.34

2.0

1.8

1.61

1.80

mmol/l

6.84

600

3062

Excessive, frequent and irregular menstruation

311

1206

1.42

7.31

1.6

1.8

1.65

1.70

mmol/l

0.49

306

1183

Gonarthrosis, primary, with knee surgery

556

3463

1.28

7.17

1.9

1.64

1.74

mmol/l

2.16

549

3372

Scabies

119

700

1.71

7.14

2.0

1.9

1.68

1.69

mmol/l

0.05

112

686

Necrotizing fasciitis

8.82

6.97

2.6

2.2

2.08

1.52

mmol/l

1.36

Keratitis

313

2277

1.38

6.94

2.0

1.8

1.62

1.72

mmol/l

1.29

306

2230

Cervical disc disorders

315

2294

1.38

6.93

2.0

1.8

1.73

1.75

mmol/l

0.13

309

2236

Malignant neoplasm of prostate, including Hilmo

281

1181

1.42

6.81

1.8

2.0

1.90

1.80

mmol/l

0.57

271

1151

Chronic sinusitis

374

2804

1.34

6.78

2.0

1.8

1.67

1.72

mmol/l

0.51

366

2734

Hepatomegaly and splenomegaly, not elsewhere classified

6.09

6.69

2.7

2.4

2.04

1.68

mmol/l

0.79

Malignant neoplasm of prostate

272

1149

1.42

6.66

1.7

2.0

1.85

1.80

mmol/l

0.29

266

1119

Other disorders of bone

165

1072

1.55

6.65

2.2

1.8

1.64

1.71

mmol/l

0.59

165

1047

Autoimmune polyglandular failure

21.28

6.52

3.0

1.6

1.97

1.30

mmol/l

—

Abscess of anal and rectal regions

438

1.87

6.51

2.2

1.8

1.61

1.69

mmol/l

0.40

428

Mycoses

771

5516

1.22

6.44

2.2

1.8

1.73

1.74

mmol/l

0.09

755

5387

Other blood glucose lowering drugs, excl. Insulins

154

994

1.56

6.43

2.3

1.8

1.85

1.60

mmol/l

3.18

154

971

Non-small cell lung cancer, adenocarcinoma, helper endpoint

386

1.92

6.33

1.7

2.0

1.57

1.68

mmol/l

0.58

374

402

2822

1.31

6.31

2.0

1.9

1.58

1.72

mmol/l

3.47

394

2758

Shoulder lesions

678

3326

1.24

6.28

1.8

1.66

1.78

mmol/l

2.09

658

3244

Injuries to the wrist and hand

912

5292

1.20

6.13

1.9

1.78

1.74

mmol/l

0.73

888

5168

Strabismus

225

1581

1.43

6.09

2.4

1.9

1.66

1.70

mmol/l

0.29

219

1549

Primary gonarthrosis, bilateral

479

3228

1.28

6.04

1.8

1.9

1.64

1.74

mmol/l

1.82

471

3143

Malignant neoplasm of mesothelium and soft tissue

190

2.30

6.00

2.5

1.9

1.87

1.76

mmol/l

0.20

184

Aneurysms, operations, SAH

150

979

1.54

5.99

1.9

2.0

1.77

1.66

mmol/l

0.69

131

962

Amputation of foot

142

2.52

5.92

3.6

1.8

1.44

1.65

mmol/l

1.27

136

Benign neoplasms

911

4211

1.19

5.86

1.9

1.8

1.73

1.77

mmol/l

0.45

890

4108

Pediculosis, acariasis and other infestations

134

857

1.57

5.85

1.9

1.71

1.70

mmol/l

0.03

127

842

Dementia, including avohilmo

456

2454

1.28

5.84

1.9

1.83

1.70

mmol/l

1.97

449

2393

Other disorders of skin and subcutaneous tissue, not elsewhere classified

131

835

1.58

5.82

2.5

1.8

1.71

1.70

mmol/l

0.05

125

813

Anosmia

7.09

5.80

1.2

1.3

2.31

1.58

mmol/l

0.80

Gonarthrosis,primary

828

4252

1.20

5.80

1.8

1.9

1.66

1.75

mmol/l

2.48

812

4143

Chronic periodontitis, complicated

486

3826

1.26

5.79

2.1

1.9

1.76

1.73

mmol/l

0.23

474

3734

Other diseases of stomach and duodenum

363

1.90

5.76

2.6

1.8

1.67

1.71

mmol/l

0.12

353

Impingement syndrome of shoulder

1450

0.60

5.50

1.6

1.8

1.59

1.75

mmol/l

1.20

1414

Other and unspecified trigeminal disorders

3.30

5.49

1.9

1.7

1.80

1.60

mmol/l

0.24

Open wound of wrist and hand

387

2942

1.29

5.49

1.9

1.76

mmol/l

0.05

378

2880

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

3.86

5.44

1.8

1.64

1.65

mmol/l

0.01

Actinic keratosis

372

2670

1.30

5.41

1.9

1.57

1.72

mmol/l

3.87

364

2609

Bell's palsy

104

640

1.64

5.38

1.8

1.73

1.67

mmol/l

0.31

104

623

Dementia

422

2277

1.28

5.38

1.9

1.83

1.69

mmol/l

1.71

415

2223

Noninflammatory disorders of female genital tract

325

1225

1.34

5.36

2.0

1.8

1.61

1.71

mmol/l

1.49

320

1201

Fitting and adjustment of other devices

146

1946

0.67

5.30

2.4

1.7

1.60

1.75

mmol/l

1.50

140

1896

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

8.04

5.29

2.5

1.5

1.33

1.56

mmol/l

0.69

Pervasive developmental disorders excl. Autism + Asperger

3.59

5.27

5.0

3.3

1.65

1.77

mmol/l

0.17

Other immunodeficiencies

3.58

5.23

2.8

1.6

1.46

1.55

mmol/l

0.15

Disorders of synovium and tendon

438

3045

1.26

5.22

1.8

1.54

1.77

mmol/l

8.14

425

2970

Skin changes due to chronic exposure to nonionizing radiation

377

2714

1.29

5.21

1.9

1.57

1.72

mmol/l

3.89

369

2653

Pain and other conditions associated with female genital organs and menstrual cycle

135

815

1.53

5.21

1.5

1.8

1.63

1.69

mmol/l

0.47

130

798

Scoliosis

405

1.79

5.18

2.3

1.8

1.72

1.64

mmol/l

0.30

398

Alkalosis

14.42

5.18

3.5

1.5

2.06

1.45

mmol/l

—

Behavioural disorders, excluding more controls

3.51

5.17

2.2

1.7

1.54

1.56

mmol/l

0.07

Nonhereditary hypogammaglobulinemia

3.66

5.10

3.2

1.9

1.65

1.56

mmol/l

0.23

Spondylolisthesis/Spondylolysis

150

1022

1.48

4.95

1.7

1.8

1.70

mmol/l

0.02

145

996

Chronic diseases of tonsils and adenoids

467

3656

0.81

4.91

1.8

1.9

1.79

1.76

mmol/l

0.28

456

3563

Seborrhoeic dermatitis

541

1.66

4.88

2.4

1.8

1.77

1.70

mmol/l

0.27

530

Paralytic ileus

208

2.10

4.87

2.7

1.8

1.66

1.71

mmol/l

0.17

202

Ulcer of oesophagus

414

1.76

4.85

2.9

2.0

1.84

1.72

mmol/l

0.34

400

Disorders of skin appendages

384

3033

1.27

4.84

1.9

1.8

1.72

1.73

mmol/l

0.10

375

2964

Monoarthritis, not elsewhere classified

182

2.17

4.83

2.0

1.6

1.37

1.64

mmol/l

1.95

173

Kela reimbursement Agammaglobulinemia (D80-84)

4.58

4.81

2.9

1.9

1.67

1.71

mmol/l

0.05

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.21

4.78

2.1

1.5

1.76

1.59

mmol/l

0.39

Metabolic disorder, other/unspecified

7.71

4.76

1.8

2.30

1.71

mmol/l

—

Alzheimer’s disease (Atypical or mixed)

109

699

1.56

4.66

1.9

1.72

1.69

mmol/l

0.12

109

684

Lifestyle-related condition

3.42

4.65

2.8

1.9

1.44

1.66

mmol/l

0.88

Appendectomy

529

4160

1.22

4.64

1.8

1.65

1.75

mmol/l

1.67

520

4063

Urethritis and urethral syndrome

2.79

4.64

2.0

1.7

1.70

1.52

mmol/l

0.59

Medical observation and evaluation for suspected diseases and conditions

469

2957

0.81

4.62

2.2

1.7

1.71

1.78

mmol/l

0.71

457

2892

Syndrome of inappropriate secretion of antidiuretic hormone

5.08

4.59

1.6

1.4

1.74

1.44

mmol/l

0.36

Osteopathy in diseases classified elsewhere

4.56

4.51

1.6

1.5

1.59

1.58

mmol/l

0.00

Gingivitis and periodontal diseases

961

4279

1.16

4.45

1.9

1.70

1.76

mmol/l

0.96

941

4178

Lumbar disc prolapse

517

3262

1.22

4.43

1.9

1.8

1.64

1.77

mmol/l

2.49

503

3180

Diseases of middle ear and mastoid

460

3063

1.23

4.40

2.2

1.8

1.80

1.74

mmol/l

0.47

450

2997

Progressive vascular leukoencephalopathy

239

0.25

4.36

1.8

1.9

1.30

1.67

mmol/l

—

231

Other strabismus

171

1221

1.40

4.34

2.4

1.9

1.62

1.70

mmol/l

0.78

166

1194

Superficial injury of ankle and foot

590

1.59

4.33

2.5

1.8

1.69

1.71

mmol/l

0.07

579

Myopia

606

1.58

4.32

2.7

1.8

1.82

1.69

mmol/l

0.57

593

Any dementia

383

2125

1.26

4.30

2.0

1.9

1.86

1.68

mmol/l

2.00

376

2077

Follicular lymphoma, hilmo

247

1.93

4.28

1.6

2.0

1.69

1.64

mmol/l

0.10

240

Listeriosis

7.23

4.22

2.7

1.3

1.97

1.58

mmol/l

—

Mental and behavioural disorders due to tobacco

463

1.66

4.19

2.8

1.9

1.56

1.64

mmol/l

0.42

453

Disorders of phosphorus metabolism and phosphatases

6.16

4.19

3.6

1.5

2.21

1.55

mmol/l

—

Cervicalgia

164

1175

1.40

4.19

2.0

1.8

1.67

1.70

mmol/l

0.16

164

1145

Defects in the complement system

4.51

4.19

2.2

1.8

1.61

1.48

mmol/l

0.18

Other neurotic disorders

235

1.94

4.17

2.4

1.9

1.94

1.61

mmol/l

1.33

230

Ulcer of vagina/vulva

109

2.42

4.17

1.5

1.9

1.58

1.69

mmol/l

0.29

109

Leiomyoma of uterus

451

2080

1.23

4.13

1.7

1.8

1.59

1.68

mmol/l

1.76

441

2031

Abnormal serum enzyme levels

165

2211

0.72

4.13

2.1

1.9

1.90

1.75

mmol/l

0.88

158

2160

Artificial joint re-operation

444

1.66

4.08

2.1

1.9

1.53

1.67

mmol/l

1.28

433

Smoking dependency

468

1.64

4.04

2.8

1.9

1.56

1.64

mmol/l

0.45

458

Subarachnoid haemorrhage

618

1.55

4.01

2.0

1.9

1.91

1.69

mmol/l

1.17

602

Appendicitis, broad definition

618

4737

1.18

3.96

1.9

1.65

1.76

mmol/l

3.10

607

4626

Medicines for HER+ breast cancer

272

2009

1.29

3.93

1.8

1.74

1.66

mmol/l

0.72

267

1962

Menorrhagia

252

1068

1.31

3.91

1.5

1.8

1.60

1.70

mmol/l

0.98

245

1047

Hypertrophic cardiomyopathy

241

1.89

3.90

2.4

2.0

1.60

1.70

mmol/l

0.38

235

Thyrotoxicosis

200

1498

1.34

3.90

1.8

1.58

1.67

mmol/l

0.81

195

1465

Other noninflammatory disorders of uterus, except cervix

172

840

1.39

3.90

1.8

1.62

1.70

mmol/l

0.63

167

826

Diseases of appendix

622

4761

1.18

3.89

1.9

1.65

1.76

mmol/l

3.13

611

4650

Diabetes mellitus in pregnancy

175

814

1.38

3.87

1.5

1.7

1.58

1.73

mmol/l

1.58

169

799

Haemolytic-uraemic syndrome

9.37

3.84

5.1

1.9

1.29

1.59

mmol/l

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.80

3.84

3.0

1.5

1.63

1.62

mmol/l

0.01

Other benign neoplasm of uterus: Other parts/unspecified

243

1.88

3.82

1.7

1.8

1.71

1.63

mmol/l

0.22

236

Lack of expected normal physiological development

3.01

3.78

2.8

2.7

1.57

1.97

mmol/l

0.70

Enthesopathies of lower limb, excluding foot

162

1182

1.38

3.75

1.7

1.8

1.65

1.71

mmol/l

0.42

157

1152

Other maternal disorders predominantly related to pregnancy

365

1845

1.24

3.75

1.7

1.8

1.66

1.69

mmol/l

0.24

352

1804

Abnormal findings in cerebrospinal fluid

7.07

3.74

4.0

1.6

1.54

1.46

mmol/l

—

Striae atrophicae

3.91

3.72

3.9

1.7

1.85

1.73

mmol/l

0.17

Other and unspecified urticaria

147

1058

1.40

3.71

1.9

1.64

1.66

mmol/l

0.10

142

1033

Disorders of vitreous body and globe

432

3431

1.21

3.70

2.1

1.8

1.52

1.74

mmol/l

7.73

419

3357

Social phobias

296

1.77

3.70

1.8

1.97

1.67

mmol/l

0.67

291

Disorders of purine and pyrimidine metabolism

4.59

3.68

2.7

1.5

1.86

1.55

mmol/l

0.92

Carcinoma in situ of skin of trunk

197

1.96

3.66

1.9

1.8

1.77

1.70

mmol/l

0.15

191

Carcinoma in situ of other and unspecified sites

226

1.89

3.63

1.8

2.0

1.69

1.75

mmol/l

0.16

220

Other intervertebral disc disorders

674

3476

1.17

3.62

1.9

1.8

1.67

1.77

mmol/l

2.02

658

3387

Proteinuria and renal glomerular damage; focal glomerulonephritis

11.37

3.61

1.8

3.3

1.28

1.43

mmol/l

—

Other disorders of the musculoskeletal system and connective tissue

123

863

1.43

3.61

2.0

1.9

1.67

1.68

mmol/l

0.01

118

840

Triptan medication for migraine, min. 3 purchases

387

2420

1.22

3.54

1.9

1.8

1.70

1.69

mmol/l

0.05

380

2359

Lesion of femoral nerve

4.36

3.54

1.0

2.0

1.76

1.56

mmol/l

0.49

Childhood allergy (age < 16)

102

570

1.48

3.48

2.0

1.9

1.71

1.78

mmol/l

0.29

102

563

Acquired coagulation factor deficiency

7.74

3.46

2.1

2.8

1.90

1.61

mmol/l

—

Adhesive capsulitis of shoulder

134

963

1.40

3.45

1.9

1.8

1.64

1.73

mmol/l

0.43

129

944

Polyuria

187

1418

1.32

3.41

2.0

1.9

1.62

1.74

mmol/l

1.04

180

1388

Special screening examination for neoplasms

404

0.42

3.41

1.4

1.8

1.92

1.79

mmol/l

0.37

395

Malignant neoplasm of breast, ER-negative, including Hilmo

150

1047

1.37

3.41

1.8

1.7

1.70

1.67

mmol/l

0.16

144

1027

Postmenopausal bleeding

211

857

1.32

3.40

2.1

1.8

1.69

1.70

mmol/l

0.06

206

842

Extrapyramidal and movement disorders

328

2672

1.23

3.34

2.2

1.9

1.69

1.71

mmol/l

0.14

319

2614

Pain associated with micturition

621

1.49

3.33

2.0

1.9

1.57

1.74

mmol/l

1.13

608

Periodontitis

851

4998

1.14

3.33

2.0

1.9

1.73

1.74

mmol/l

0.13

828

4884

Disorders of vitreous body

417

3360

1.20

3.31

2.1

1.8

1.52

1.74

mmol/l

7.49

404

3286

Other enthesopathies

219

1705

1.29

3.29

1.8

1.74

mmol/l

0.01

214

1666

Brain meningioma

206

1.86

3.22

1.3

1.9

1.73

mmol/l

0.00

201

Symptoms and signs involving the skin and subcutaneous tissue

589

4965

1.16

3.20

2.0

1.9

1.67

1.73

mmol/l

0.98

577

4852

Erectile dysfunction

498

1.54

3.19

1.8

2.1

1.90

1.73

mmol/l

0.74

485

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

4.69

3.16

3.0

1.5

1.81

1.58

mmol/l

—

Malignant neoplasm of breast, HER-negative

136

978

1.37

3.14

1.8

1.73

1.66

mmol/l

0.32

131

960

Arthropod-borne viral fevers and viral haemorrhagic fevers

526

1.51

3.09

1.9

1.51

1.68

mmol/l

1.61

514

Other disorders of breast

626

0.56

3.08

1.7

1.57

1.65

mmol/l

0.20

613

Chronic periodontitis, including avohilmo

844

4997

1.13

3.05

2.0

1.9

1.73

1.74

mmol/l

0.11

822

4882

Other/unspecified enthesopathies of lower limb, excluding foot

322

1.66

3.05

2.0

1.8

1.52

1.63

mmol/l

0.68

314

Secondary lactase deficiency

10.98

3.05

1.4

1.8

1.62

1.54

mmol/l

—

Flatulence and related conditions

3.40

3.04

2.2

1.8

1.63

1.72

mmol/l

0.20

Pregnancy hypertension

253

1814

1.25

3.01

1.6

1.7

1.69

1.65

mmol/l

0.22

247

1772

Voice disturbances

206

1613

1.28

3.01

1.9

1.8

1.55

1.69

mmol/l

1.79

200

1583

Conduct disorder

2.43

2.98

2.1

2.0

1.54

1.73

mmol/l

0.45

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

282

1990

1.23

2.96

1.7

1.8

1.68

1.67

mmol/l

0.09

274

1945

Hypoplasia of dental enamel, prenatal

5.86

2.95

10.1

2.1

1.67

1.55

mmol/l

—

Fracture of forearm

443

3442

1.18

2.94

1.9

1.8

1.68

1.70

mmol/l

0.17

429

3365

Carcinoma in situ, bladder

206

1.82

2.93

1.6

2.0

1.63

1.75

mmol/l

0.38

201

Tuberous sclerosis 1

7.13

2.92

1.8

3.4

1.58

1.69

mmol/l

—

Stomatitis and related lesions

151

1139

1.33

2.92

1.9

1.59

1.67

mmol/l

0.62

146

1113

Severe mental retardation

7.04

2.91

2.7

2.0

1.72

1.37

mmol/l

—

Medical abortion

455

2088

1.18

2.90

1.9

1.8

1.66

1.70

mmol/l

0.38

444

2038

Pleural plaque without asbestos

229

1.77

2.89

2.9

2.0

1.76

1.70

mmol/l

0.16

224

Motor disorders, excluding more controls

2.83

2.84

3.3

3.0

1.45

1.60

mmol/l

0.48

Artrosis, including avohilmo

726

3490

1.14

2.82

1.8

1.9

1.73

1.76

mmol/l

0.25

710

3395

Cachexia

4.58

2.82

4.1

1.3

1.77

1.88

mmol/l

—

Other benign neoplasms of uterus

300

1.65

2.78

1.7

1.8

1.70

1.65

mmol/l

0.15

291

Acute appendicitis

559

4538

1.15

2.76

1.9

1.63

1.76

mmol/l

3.01

548

4433

5.17

2.76

1.4

2.6

1.61

1.62

mmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

240

1.73

2.76

2.1

1.9

1.59

1.66

mmol/l

0.29

233

Other disorders of pigmentation

225

1.75

2.75

2.0

1.8

1.78

1.69

mmol/l

0.15

220

Dementia due to Parkinsons disease, excluding more controls

2.17

2.72

2.0

1.8

2.42

1.64

mmol/l

0.61

Other epidermal thickening

226

1.74

2.71

2.0

1.8

1.52

1.67

mmol/l

0.59

221

Other disorders of eyelid

382

3074

1.19

2.70

1.9

1.67

1.73

mmol/l

0.71

376

3003

Other arthrosis

418

2459

1.18

2.68

1.8

1.9

1.69

1.79

mmol/l

1.27

407

2391

Any prescribed medicine buy

6.94

2.60

1.5

2.8

1.92

1.60

mmol/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.69

2.60

1.3

1.4

1.51

1.62

mmol/l

—

Other diseases of hard tissues of teeth

530

2371

1.16

2.59

2.0

1.8

1.74

1.77

mmol/l

0.26

520

2316

Rhabdomyosarcoma, including Hilmo

7.61

2.59

3.4

1.4

1.60

2.20

mmol/l

—

Other infective spondylopathies

7.53

2.58

1.8

1.3

2.02

1.50

mmol/l

—

Assault by hanging, strangulation and suffocation

7.45

2.58

1.0

1.9

1.40

2.47

mmol/l

—

Exposure to controlled fire, not in building or structure

7.41

2.57

4.6

1.9

2.54

1.71

mmol/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate [Moles/volume] in Capillary blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS